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ABSTRACT
Individuals on antipsychotic medications have been found to be
disproportionately affected by overweight and obesity which increases their
cardiometabolic risk. Psychoeducation has been found to be an effective strategy for risk
reduction of cardiometabolic risks. This intervention examined the effectiveness of a
psychoeducational intervention in adults (aged 18 and above) with severe mental illness.
The four session, 8 week intervention encouraged an increase in fruit and vegetable
intake and engagement in physical activity. The conceptual frameworks included the
Health Promotion Model and Chronic Care Model. Outcome measures included nutrition,
physical activity and health promoting behaviors. Biological outcomes included weight,
BMI, blood pressure, pulse, waist circumference, and waist-hip ratio. The HealthPromoting Lifestyle Profile II (HPLP II) questionnaire was used to measure health
promoting behaviors. The sample that completed the intervention consisted of 19 adults.
Results of paired sample t-tests indicate that at the end of the intervention there
were significant changes in the fruit intake, vegetable intake and time spent engaged in
physical activity. Twelve of the 19 participants lost weight at the end of the intervention.
However, there were no significant statistical changes in any biological variable. Paired
sample t-tests of the pre and post intervention 52 item HPLP II questionnaire indicated
significant changes in the total 52 item scale, and physical activity and spiritual growth
subscales. These findings suggest that an 8 week psychoeducational intervention can
have an impact on the nutrition, physical activity and health promoting behaviors.
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CHAPTER 1
INTRODUCTION

For patients with schizophrenia, bipolar disorder, clinical depression, or other
mental illnesses, the advent of psychotropic drugs improved the management of their
symptoms and quality of life. Antipsychotic drugs, now in a second generation form, are
an example of drugs that have helped people live better lives. Second generation
antipsychotic medications (SGAs) also known as atypical antipsychotics have provided a
clear benefit for many patients due to their reduced propensity to cause extrapyramidal
effects often associated with older, conventional antipsychotics (Newcomer, 2004).
However, adverse side effects have not evaded the use of antipsychotic drugs. A major
concern for the use of many antipsychotic medications is their significant association
with weight gain, obesity, which in turn increases cardiovascular risk (Fleischhacker et
al., 2008; Maayan & Correll, 2010).
Weight Gain Associated with Antipsychotic Medications
A disproportionate burden of weight gain has been noted in patients who are
taking antipsychotic medications. It has been indicated that none of the antipsychotic
agents should be considered entirely body-weight-neutral, as the proportion of
individuals who experience clinically significant weight gain (defined as ˃7% of
pretreatment body weight) is greater with any antipsychotic agent than with placebo
(Citrome, 2007). All antipsychotic drugs have been found to cause notable weight gain
in patients who are taking these agents for the first time (Tarricone, Ferrari, Serretti, &
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Berardi, 2010). The threat of weight gain has also been found to differ among different
antipsychotic medications. For example, multiple controlled studies have shown that all
SGAs are associated with weight gain compared with placebo treatment, although some,
such as olanzapine, clozapine, and quetiapine are more problematic than others such as
ziprasidone and aripiprazole (Das, Mendez, Jagasia, & Labbate, 2012).
Weight gain and obesity are increasingly becoming a growing public health
concern facing Americans. It has been estimated that more than one-third of adults in the
United States are obese (CDC, 2012). The escalation of various chronic medical
conditions has also been attributed to obesity. Obesity has been associated with increases
in health complications such as cardiovascular diseases, hypertension, dyslipidemia,
stroke, gallbladder disease, osteoarthritis, sleep apnea, respiratory problems, certain
cancers and Type 2 diabetes. Obesity has a great impact on health care spending. In
2008, obesity was associated with a total cost of $147 billion. Medical costs for people
who are obese were $1,429 higher than for those with normal weight (CDC, 2012).
Up to 80% of individuals treated with antipsychotics have been found to suffer
from medication-induced weight gain and 40% to 60% of persons with schizophrenia are
obese as compared to 20% prevalence in the general United States adult population
(Green, Patel, Goissman, Allison, & Blackburn, 2000). Mental illness has been found to
predispose individuals to becoming overweight or obese. There is evidence that,
compared with the general population, people with early-stage and/or without medication
or with previously untreated schizophrenia and bipolar disorder are at increased risk of
having increased body mass index (BMI) ≥ 25 kg/m2 corresponding to the medical
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diagnosis of overweight, or BMI ≥30 kg/m2 corresponding to obesity and central obesity
(De Hert et al., 2011; Maina, Salvi, Vitalucci, D'Ambrosio, & Bogetto, 2008). Further
evidence indicates that there is a 2.8 to 3.5 fold increase in the risk of obesity in patients
with schizophrenia and 1.2 to 1.5 fold increase in patients with major depression or
bipolar disorder. Overall, weight gain is a well-established adverse effect of acute and
maintenance antipsychotic treatment in patients with schizophrenia, and affects between
15% and 72% of patients (De Hert et al., 2011; Maina et al., 2008). Evidence further
suggests that similar effects occur in patients with bipolar disorder on antipsychotic
medications (De Hert, et al., 2011).
According to Stahl (2008), some of the atypical antipsychotic agents are
associated with significant cardiometabolic risks. These risks include weight gain,
obesity, dyslipidemia, diabetes, accelerated cardiovascular disease, and premature death.
The “metabolic highway” (Stahl, 2008, p. 388 ) begins with increased appetite and
weight gain which progresses to obesity, insulin resistance, and dyslipidemia with
increase in fasting triglyceride level. Ultimately, hyperinsulinemia advances to
pancreatic beta cell failure, prediabetes and diabetes. Once diabetes has been established,
the risk for cardiovascular events and premature death is further increased.
Many patients taking psychotropic medications gain enough weight to adversely
affect their health. Losing this weight, even after the psychotropic drug is discontinued,
can be difficult (Sachs & Guille, 1999). Obesity and medication related weight gain have
also been observed to play a role in treatment outcomes by decreasing treatment
adherence (Loh, Meyer, & Leckband, 2006; Weiden, Mackell, & McDonnell, 2004).
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Patients may stop taking medication prematurely due to concern of weight gain. In
patients with schizophrenia, data indicate that obese patients are 2.5 times more likely to
miss taking their antipsychotic than those with BMI in the normal range of less than
25kg/m2 (Weiden et al., 2004). Weight gain and obesity also have social consequences to
the individuals who are affected. It has been observed that excess weight and obesity
leads to social withdrawal as a result of stigmatization and discrimination (Kurzthaler &
Fleischhacker, 2001).
There have been different theories regarding the mechanism underlying the
association observed between antipsychotic medications and weight gain. To date,
mechanisms underlying antipsychotic cardiometabolic adverse effects are incompletely
understood.
Correll, Lencz and Malhotra (2011) discuss that
recent clinical, molecular and genetic data suggest that: (a) antipsychotic-naive
samples provide the greatest power for mechanistic study; (b) weight and
metabolic effects can be discordant with overlapping and distinct mechanism; (c)
antipsychotics affect satiety and energy homeostasis signaling; (d) the specific
peptide mediating these effects is unknown but overlaps with those involved in
idiopathic obesity; and (e) single nucleotide polymorphisms in genes encoding
known neurotransmitter receptors and metabolic proteins are promising
pharmacogenomic targets for countering adverse effects. (pp.97)
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Weight Gain Independent of Antipsychotic Medications
Other than antipsychotic medications, it has been observed that multiple factors
contribute to the risk for obesity among patients with mental illness. Behavioral and
environmental risk factors contribute to overweight and obesity in patients with mental
illness. Lifestyle factors including poor dietary habits, lack of exercise or limited activity
and inactivity due to negative symptoms have been hypothesized as contributors of
weight gain in patients with schizophrenia (Basu et al., 2004). Many patients with
schizophrenia also live in group homes which may promote sedentary living and rarely
provide diets to manage weight (Cjafetz, White, Collins-Bride, & Nickens, 2005).
Physiological factors also play a role in weight gain.
Ryan and Thakore (2002) indicate that patients with schizophrenia have an
increased propensity for storing excess fat as intraabdominal (visceral) adiposity. Low
baseline body mass index (BBMI) has also consistently been demonstrated to be a
demographic risk factor with nearly every SGA (Gebhardt et al., 2009). Low BBMI
patients consistently gain weight at an increased rate compared with their heavier
counterparts. It has been suggested that low BBMI patients may have a higher resting
metabolic rate and thus weight gain may be explained by a proportional decrease in
metabolic rate in response to drug therapy. However, low BBMI may be associated with
the fact that many of these individuals have lost considerable weight due to their
untreated illness. Kurzthaler and Fleischhacker (2004) indicate that positive symptoms
may lead to weight loss when patients stop eating to “cleanse” themselves or because of
command hallucinations. Weight increase in such patients may reflect symptom
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reduction and improvement. Additionally other significant predictors of risk of weight
gain have been determined to be a younger age at treatment initiation, female sex, first
exposure to antipsychotics, family history of high BMI, and non-smoking status
(Gebhardt et al., 2009).
Interventions Used for Weight Management
Modest weight loss has been associated with health benefits, including improved
cardiovascular health among individuals who are overweight or obese (National Institutes
of Health [NIH], 1998). It has been recommended that weight prevention programs
should be initiated when patients begin antipsychotic treatment in an effort to prevent or
decrease weight gain (Littrell, Hilligoss, Kirshner, Petty, & Johnson, 2003). Dixon et al.
(2009) also recommend that individuals with schizophrenia who are overweight
(BMI=25.0 -29.9) or obese (BMI ≳30.0) should be offered a psychosocial weight loss
intervention to promote weight loss. The key elements of psychosocial interventions
proposed for weight loss include psychoeducation focused on nutritional counseling,
caloric expenditure, and portion control; behavioral self-management including
motivational enhancement, goal setting, regular weigh-ins, self-monitoring of daily food
and activity levels; and dietary and physical activity modification.
Clinical guidelines also recommend that adults should avoid sedentary lifestyles
by being active (U.S. Department of Health and Human Services [USDHHS], 2008).
Additionally, it is indicated that some physical activity is better than none and adults who
participate in any amount of physical activity gain some health benefits. Regular activity
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has also been recommended for adults with chronic conditions due to the resulting health
benefits.
There is an increasing interest to develop treatment alternatives to control weight
gain in patients on antipsychotic medications. Maayan and Correll (2010) suggest three
strategies that can be utilized to manage antipsychotic induced weight gain that include
switching to a less metabolically adverse antipsychotic, adjunctive behavioral treatments,
and adjunctive pharmacological treatments. However each of these strategies has been
found to be only modestly effective. Furthermore weight was not decreased to
pretreatment level particularly in antipsychotic-naive patients even when interventions
were co-initiated with antipsychotics. Among different behavioral interventions, group
and individual treatment, dietary counseling and cognitive-behavioral therapy seem to be
similarly effective. Among 15 different pharmacological strategies the most evidence
available was for metformin; however there was lack of availability of head-to-head trials
comparing individual pharmacologic interventions. Another study by Faulkner, Cohn,
and Remington (2007) reviewed interventions to reduce weight gain in schizophrenia and
concluded that there was insufficient evidence to support the general use of adjunctive
pharmacological interventions to reduce weight gain in schizophrenia.
Literature has indicated lack of support for the use of pharmacological
interventions. Psychoeducational interventions are important for the target patient
population, and may decrease cardiometabolic risk factors. More importantly the
psychoeducational intervention may impart knowledge and skills that may promote
healthy lifestyles in the target population.
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Significance of the Project
There is a growing practice problem facing clinicians on how to prevent weight
gain in patients on antipsychotic medication. One recommended approach to treating
antipsychotic-induced-weight gain is switching the antipsychotic (Das, Mendez, Jagasia,
& Labbate, 2012). Das et al. found that there are a few studies evaluating if the switch
works, and there is almost no evidence about the long-term weight loss benefits of
switching.
The psychopharmacology of weight loss with drugs that have been studied to
promote weight loss in patients on antipsychotic medications is poorly understood (Das et
al., 2012). Additionally, there is little evidence that pharmacologic treatment is superior
to behavioral treatment. Despite the lack of research on combining behavioral and
pharmacologic treatment, Das et al. doubt the effectiveness of pharmacological
treatments without behavior change.
This project is significant as it is clear that interventions targeting behavioral
modification are the cornerstone of weight loss treatment in clients on antipsychotic
medications (Das et al., 2012). Weight gain has an appalling impact on those who
experience it and on the society at large. Implementation of interventions that focus on
prevention of weight gain or obesity is crucial. It has been reported that patients with
severe mental illness have limited access to general somatic health care and receive less
somatic health care than patients without mental illness (Fleischhaker et al ., 2008).
Furthermore even when somatic health care is provided it has been reported to be of a
lower quality than that for patients without serious mental disorders. The disparities in
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health service delivery and treatment provision can therefore hamper the recognition of
overweight and obesity in patients with mental illness.
Many clinicians will be interested in whether non-pharmacological interventions
like the implementation of a psychoeducation intervention for patients on antipsychotic
medication will prevent weight gain or lead to weight loss. This project intervention
which focuses on a non-pharmacological psychoeducation intervention for patients on
antipsychotic medications with the aim of preventing weight gain or obesity is an
important step. The implementation is also an attempt to develop a best practice approach
that can improve patient outcomes in an already vulnerable population. Advanced
Practice Nurses (APNs) have a key role to play in improving outcomes for vulnerable
populations. The overall implication for APNs is therefore to implement interventions
that will target weight gain and obesity in patients managed by antipsychotic
medications. Given the significant threat of antipsychotic medication related weight gain
to the course of mental illness, quality of life, health complications, health outcomes and
healthcare spending, it is imperative to examine whether a nurse practitioner-led nonpharmacological intervention will facilitate prevention of weight gain.
Target Population
The proposed project was conducted at a Community Mental Health Clinic in a
mid-western city in the United States. The target population included patients taking at
least one antipsychotic medication. The populations served at the project site are
community case management clients who have serious mental illness or co-occurring
disorder (mental health, medical health, or substance use).
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Purpose of the Project
The prevalence of overweight and obesity in the mental health population is
concerning. Overweight and obesity is the precursor of increased cardiometabolic risks.
Unhealthy lifestyle and environmental factors further escalate the problem. It is therefore
important to investigate whether the implementation of a psychoeducation intervention
will be beneficial to an already vulnerable population.
The purpose of the project was therefore to (a) study the effect of an
individualized psychoeducation intervention on nutrition, physical activity, weight, BMI,
blood pressure, waist circumference, waist/hip ratio in adult patients (aged 18 and above)
with severe mental illness who are on antipsychotic medications; and (b) evaluate the
effect of an individualized psychoeducation intervention on health promoting lifestyles of
adult patients (aged 18 and above) with severe mental illness who are on antipsychotic
medications.
Translational Project Question
The guiding questions in the project were (a) What effect does an individualized
psychoeducational intervention have on nutrition, physical activity, weight, BMI, blood
pressure, waist circumference, waist/hip ratio in adult patients (aged 18 and above) with
severe mental illness who are on antipsychotic medications ? (b) What effect does an
individualized pychoeducational intervention have on health promoting lifestyles of adult
patients (aged 18 and above) with severe mental illness who are on antipsychotic
medications?
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CHAPTER 2
REVIEW OF LITERATURE

The purpose of this project was to implement a psychoeducational intervention
that would increase awareness of nutrition and physical activity for adults (aged 18 and
above) with severe mental illness who are taking antipsychotic medications. The second
purpose of the intervention was to determine if the intervention had any effect on weight,
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting
lifestyles among this group of adults.
The purpose of this chapter is to review literature relative to nonpharmacological interventions that are used to prevent weight gain in patients on
antipsychotic medications. Modes of delivery of education in patients with mental illness
are also discussed. To explore current literature focusing on interventions for prevention
of weight gain in patients on antipsychotic medications, the following databases were
reviewed: CINAHL; Cochrane Review; PubMed; Proquest: and PsycINFO. Keywords or
phrases for this review included weight gain; weight loss; weight prevention;
psychoeducation; antipsychotics; second generation antipsychotics; atypical
antipsychotics; non-pharmacologic; behavioral therapies; schizophrenia; and metabolic
syndrome. Keywords used to review modes of education delivery were education;
mental health; antipsychotics; and systematic review. Additionally, the reference lists of
all retrieved literature were reviewed for potential inclusion.
The risk of metabolic syndrome associated with various atypical antipsychotic
medications has been described across numerous studies with higher effects seen for
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certain antipsychotic medications on weight gain, waist circumference, fasting
triglyceride level, and glucose levels (Riordan, Antonini, & Murphy, 2011). Studies have
shown that the prevalence of metabolic syndrome and cardiometabolic risk factors, such
as overweight, hypertension, dyslipidemia and glucose abnormalities are substantial in
patients with mental illness in the United States. The Clinical Antipsychotic Trial of
Intervention Effectiveness (CATIE) clinical trials, which included 1361 patients
receiving antipsychotic treatment, documented a 35.8 % prevalence of metabolic
syndrome (McEvoy et al., 2005).
Another study by Correll et al. (2010) involved a one-day national
cardiometabolic screening program for patients in a variety of public mental health
facilities, group practices, and community behavioral health clinics. The study was
carried out between 2005 and 2008 and included a total of 10,084 patients at 219 sites.
The study found that for the overall sample, the mean waist circumference was 41.1
inches for men and 40.4 inches for women; 27% were overweight (body mass index
[BMI] 25.0-29.9 kg/m2), 52% were obese (BMI ≥ 30.0kg/m2), 51% had elevated total
cholesterol ( ≥ 200mg/dl), 59% had a low level of high-density lipoprotein cholesterol (<
40mg/dl for men or < 50mg/dl for women), 45% had elevated triglycerides ( ≥ 150
mg/dl), and 33% had elevated fasting glucose ( ≥ 100mg/dl).
To clinicians, an increasingly difficult practice problem is how to prevent weight
gain in patients on antipsychotic medications in order to improve patient outcomes.
Riordan et al. (2011) recommend that programs aimed at improving clinical measures
associated with metabolic syndrome may decrease important risk factors, improve
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patients’ quality of life and significantly reduce healthcare costs. One suggested
approach to treating antipsychotic-induced weight gain is switching the antipsychotic
(Das et al., 2012). According to Das et al., additional long-term studies are required to
influence the clinical practice since the psychopharmacology of weight loss with some of
these medications is poorly understood. Furthermore, Das et al. found little evidence that
pharmacologic treatment is superior to behavioral treatment. Of medications studied, only
sibutramine and topiramate showed appreciable modest weight loss of approximately 2 to
3 kg in short-term studies compared to placebo.

Despite the lack of research combining

behavioral and pharmacologic treatment, Das et al. doubt the effectiveness of
pharmacologic treatments without behavior change. It is therefore likely that
interventions targeting behavioral modification are the cornerstone of weight loss
treatment in clients on antipsychotic medications (Das et al., 2012). According to Das et
al., behavioral treatments have been found to lead to modest weight loss, compared to
controls, ranging from 0.5 kg to 4.0 kg.
Many clinicians will be interested in whether non-pharmacological interventions
like the implementation of a psychoeducation intervention for patients on antipsychotic
medication will prevent weight gain or lead to weight loss. According to Dixon et al.
(2009) in the Schizophrenia Patient Outcomes Research Team (PORT), psychosocial
treatment recommendations and summary statements recommend that individuals with
schizophrenia who are overweight (BMI=25.0-29.9) or obese (BMI≥30.0) should be
offered a psychosocial weight loss intervention that is at least three months in duration to
promote weight loss. The key elements of psychosocial interventions for weight loss
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include psychoeducation focused on nutritional counseling, caloric expenditure, and
portion control; behavioral self-management including motivational enhancement; goal
setting; regular weigh-ins, self-monitoring of daily food and activity levels; and dietary
and physical activity modification.
Dixon et al. (2009) mention that while the evidence for intervention for weight
loss is strong enough to warrant a recommendation, the current state of the literature
exploring psychosocial interventions for the prevention of weight gain among individuals
with schizophrenia is not substantial enough to warrant a formal recommendation by the
PORT. The absence of randomized controlled studies has been a key setback in
developing evidence-based interventions that can manage weight loss among this
population. To date only a few randomized control trials (RCTs) targeting the prevention
of weight gain among individuals with schizophrenia who had recently begun taking
antipsychotic medications have been published.
Due to the lack of consensus on management of antipsychotic medication induced
weight gain, an attempt has been made to review all relevant literature pertaining to
current strategies. To adequately develop a comprehensive weight prevention
intervention for clients on antipsychotic medications, investigating existing programs and
reviewing elements that contributed to their success is necessary. The goal of the review
is for the literature to guide and support the design of the intervention that will contribute
to the greatest outcome.
Two approaches to non-pharmacological management of weight management
have been identified in the literature including psychoeducation and cognitive behavioral
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interventions. The existing literature reviewed will be compared by study design,
methods, theoretical framework, study setting, participants, inclusion and exclusion
criteria, variables, scales and statistical tests, findings, limitations of the study, and
implications for clinical practice.
Meta-Analyses
Five key meta-analyses concerned with weight management in patients on
antipsychotic medications have been reviewed. Das, Mendez, Jagasia, and Labbate
(2012) performed a comprehensive literature review of all controlled clinical trials for
pharmacological and/or behavioral management of SGA-induced weight gain in
schizophrenia patients by searching PubMed and Google Scholar. They used
combinations of search terms schizophrenia, weight gain, weight loss, antipsychotics,
behavioral therapies, non-pharmacologic, second-generation antipsychotic, and switching
with limits of clinical trials. A total of 63 studies were reviewed and analyzed. The
studies were combined using meta-analytic techniques to assess the impact on weight
change of various pharmacologic and behavioral treatments. Studies were classified in
the same group if they addressed a similar question (i.e., weight loss caused by a specific
pharmacologic intervention). The analysis showed that sample sizes were generally
small. Clinical trials were six weeks to one year, and weight loss was modest with any
treatment. Several adjunctive pharmacologic treatments showed no weight loss;
sibutramine, metformin, and topiramate showed some benefit. Amantadine and orlistat
were somewhat less effective and had lower rates of tolerability. The analysis also found
that among behavioral therapies, nutritional counseling combined with exercise showed
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the most benefit. Behavioral therapies showed modest but most consistent benefits
compared with controls. The authors concluded that scheduled pharmacologic treatment
to prevent weight gain or promote weight loss in schizophrenia patients on SGA therapy
was limited based on the review. They also concluded that switching antipsychotic
agents has not been established as a long-term solution and additional long-term studies
were required to influence clinical practice. This study suggests that non-pharmacologic
interventions may be beneficial to clients on antipsychotic medications.
Alvarez-Jimenez, Hetrick, Gonzalez-Blanch, Gleeson, and McGorry (2008)
carried out a systematic review and meta-analysis of RCTs. The inclusion criteria were
RCTs of a specific non-pharmacological adjunctive intervention aimed at prevention or
controlling antipsychotic-induced weight gain, with at least 75% of participants who had
been diagnosed with schizophrenia-spectrum disorders using either the Diagnostic and
Statistical Manual (DSM) or International Code of Diagnosis (ICD). A total of ten trials
with interventions lasting between eight weeks and six months were included in the metaanalysis. The participants were either young adults with recent-onset psychosis or adults
with chronic schizophrenia, hospitalized or out-patients, and receiving treatment with
first- or second-generation antipsychotic drugs. The primary outcome was considered to
be mean change in body weight and BMI by the end of the intervention, while the
secondary outcome measure included mean change in both body weight and BMI by
follow-up. Additional secondary outcome measures comprised mean change of ratings of
quality of life, medication adherence and relapse rates. A total of 482 patients were

27

included in the RCTs that compared non-pharmacological interventions with treatment as
usual.
Alvarez-Jimenez et al. (2008) found that there was a statistically significant
reduction in mean body weight for participants in the non-pharmacological intervention
groups compared with those on treatment as usual (weight mean difference, WMD=-2.56
kg, 95% CI -3.20 to -1.92kg, p< 0.0001) . The pooling treatment effects of mean BMI
change across all interventions yielded similar significant results in favor of the nonpharmacological interventions (WMD=-0.91kg/m2, 95% CI -1.13 to -0.68kg/m2,
p<0.0001). The study also observed that pooling treatment effects change in body weight
and in BMI demonstrated statistically significant advantages of non-pharmacological
interventions at follow-up. The study concluded that adjunctive non-pharmacological
interventions, whether individual or group interventions, or cognitive behavioral therapy
with nutritional counseling, were effective in reducing or attenuating antipsychoticinduced weight gain compared with treatment as usual. Additionally treatment effects of
non-pharmacological interventions were maintained to follow-up. Similarly this metaanalytic review consistently found that non-pharmacological interventions led to
significant weight loss in patients on antipsychotic medications. These findings are
notable and support the potential of a non-pharmacological psychoeducation intervention
to facilitate weight loss in participants aged 18 years and older who are on antipsychotic
medications.
Faulkner, Cohn, and Remington (2007) reviewed studies with the objective of
determining the effects of both pharmacological (excluding medication switching) and
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non-pharmacological strategies for reducing or preventing weight gain in individuals with
schizophrenia. Key databases and the Cochrane Schizophrenia Group’s trials register and
reference sections within relevant articles were searched. The authors also hand searched
key journals and contacted first authors of each relevant study and other experts to collect
further information. The selection criteria included RCTs that compared any
pharmacological or non-pharmacological intervention for weight gain (e.g., diet and
exercise counseling including those with elements of cognitive and /or behavioral
modification) with standard care or other treatments for individuals with schizophrenia or
schizophrenia-like illnesses. Weighted mean differences of the change in weight from
baseline were calculated. Where heterogeneity existed (determined by a chi-square test),
a random-effects model was used. The primary outcome measure was weight loss.
Twenty-three RCTs met the inclusion criteria for the review (Faulkner et al.,
2007). Five trials assessed a cognitive/behavioral intervention while eighteen trials used
a pharmacological adjunct. Two cognitive/behavioral interventions showed significant
mean weight change at the end of the treatment (2 RCTs, n=104, WMD=-3.38kg, CI 4.81 to -1.96). Three cognitive/behavioral trials showed significant treatment effect at
end of treatment (3 RCTs, n=129, WMD=-1.69 kg, CI -2.77 to -0.61). Pharmacological
adjunct showed an overall treatment effect (9 RCTs, n=273, WMD=-2.97 KG, CI -4.48
to -1.46). The study concluded that modest short-term weight loss can be achieved with
selective pharmacological and non-pharmacological interventions. According to the
authors, interpretation of the study was limited by the small number of studies, small
sample sizes, short study durations, variability of the interventions themselves, and

29

intensity and duration of study. The sample sizes in most studies ranged between 14 and
171. The duration of the trials ranged between six weeks and twenty-four weeks. The
average duration was found to be approximately twelve weeks. All the five
cognitive/behavioral studies were not double-blind due to the inherent difficulty involved
in disguising psychosocial interventions. Out of the eighteen pharmacological
interventions, sixteen were double blind and two were open.
A systematic review was conducted on the effectiveness of interventions designed
to control weight gain in schizophrenia (Faulkner, Soundy, & Lloyd, 2003). A total of 16
studies met the inclusion criteria. Eight studies which included behavioral (including diet
and /or exercise) interventions reported consistent small reductions in or maintenance of
weight. The authors concluded that incorporating multiple components of diet, exercise
and/or behavioral counseling were all successful in limiting weight gain. Additionally
they concluded that both dietary and exercise counseling set within a behavioral
modification program is necessary for sustained weight control. The authors mention
that weak study designs and small sample sizes observed in many studies were a
limitation.
Faulkner and Cohn (2006) undertook a selective review of interventions for
weight gain and metabolic disturbance in the general population and in individuals
treated with antipsychotic medications focusing on RCTs in schizophrenia. The review
analyzed both pharmacological and non-pharmacological interventions. Four RCTs of
non-pharmacological interventions were identified. They had a total of 208 participants
(98 men and 110 women) with an average age of 36.14 years and an average weight of

30

87.99 kg at the start of the study (as well as average BMI of 29.09 kg/m2, reported in
three of the studies). The participants were primarily outpatients taking olanzapine in
three studies. The length of the interventions ranged from 14 weeks to three months.
Three studies involved cognitive-behavioral group interventions incorporating education
and discussion regarding diet and physical activity, and one study used one-on-one
dietary counseling. Faulkner and Cohn mention that the intervention sessions included
individual and group work, written exercises, tests, and discussions to develop and
rehearse self-monitoring skills (for example, modifying urges to overeat and changing
snacking habits) and set regularly reviewed healthy-eating lifestyle goals. Three studies
involving cognitive-behavioral interventions confirmed that modest weight-gain
prevention or weight loss is possible in the short term, although there were no statistically
significant findings in two studies. The authors mention that the limitation of the review
was the small number of rigorous RCTs of short-term duration and the small sample
sizes.
Literature Review on Psychoeducation Interventions
The aim of psychoeducation (or patient education/teaching) in patients with
mental illness is to increase knowledge and understanding of their illness and treatment
(Xia, Merinder, & Belgamwar, 2011). Psychoeducational interventions involve the
interaction between the information provider and mentally ill person. Psychoeducation
interventions are brief and inexpensive making them attractive to managers and policy
makers.
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A study was carried out over a six month period with an aim of assessing the
effect of an education intervention on antipsychotic-induced weight gain among patients
with schizophrenia who were being treated with olanzapine (Littrell, Hilligoss, Kirshner,
Petty, & Johnson, 2003). The study was a quasi-experimental design with 70 patients
with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder. Patients were
randomly assigned to an intervention group or a standard care group. For over four
months, the intervention group participated in weekly psychoeducation classes that
focused on nutrition, exercise, and living a healthy lifestyle. The participants were
followed for an additional two months to assess weight change.
The study found a statistically significant difference in weight change between the
two groups at post-treatment and at endpoint (Littrell et al., 2003). At the endpoint of the
study, the mean weight change of the intervention group was -0.06 pounds, while the
mean weight change in the standard care group was an additional 9.57 pounds. The study
concluded that a structured educational intervention might have a positive effect on
antipsychotic-induced weight gain among patients with schizophrenia. Study limitations
included unclear effects of dosing of olanzapine since it was prescribed in a flexible-dose
manner and concomitant medication use in some patients. The relatively short study
duration and lack of measuring subjects’ extraneous variables such as medication history
and familial trends for subjects in the two groups was also recognized as a limitation. It
is encouraging that their study showed that a simple group psychoeducation intervention
attained a clinically meaningful outcome for participants.
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Wu et al. (2008) carried out a 12 week study to compare the effectiveness of
several interventions in reducing the weight gain associated with the use of antipsychotic
agents in patients with schizophrenia. The study included patients who were 18-45 years
of age. Patients were randomized to receive metformin alone (750 mg per day), placebo
alone, lifestyle intervention plus metformin, or lifestyle intervention and placebo.
Lifestyle interventions consisted of a psychoeducation approach with an emphasis on the
role of eating and exercise on weight management, including a dietary intervention
recommended by the American Heart Association, and exercise programs initiated at the
study site and continued at home. Out of the 128 eligible patients, 118 completed the
study: 30 patients in the lifestyle intervention plus metformin group, 30 patients in the
metformin alone group, 29 patients in the lifestyle intervention plus placebo group, and
29 patients in the placebo alone group.
Wu et al. (2008) found that lifestyle-plus metformin group had a mean decrease in
BMI of 1.8 (95% CI, 1.3-2.3). The metformin-alone group had a mean decrease of 1.2
(95% CI, 0.9 to -1.5) in BMI. Lifestyle group had a mean decrease of 0.5(95%CI, -0.3 to
-0.8). The placebo group had a mean increase in weight gain of 1.2 (95% CI, 0.9 -1.5).
Analysis of variance (ANOVA) was used to compare all continuous variables. Statistical
comparisons among the interventions showed the metformin plus lifestyle group had
results that were statistically significant compared to all other interventions. In addition,
all interventions were superior to placebo. The study concluded that all interventions
were better than placebo alone for producing weight loss in patients with schizophrenia
who had gained weight from atypical antipsychotic medications. The limitation when
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interpreting this study is that some interventions were multicomponent making it difficult
to define which strategies worked best.
Vreeland, Minsky, Gara, and Toto (2010) carried out a study to examine the
effectiveness of a manualized, psychoeducational wellness toolkit called the Solutions for
Wellness (SFW). The aim of the study was to examine whether mental health consumers
who volunteered to participate in an intensive group intervention with the SFW program
increased knowledge about wellness and changed their attitude/intentions to pursue
healthier lifestyle choices. The primary outcome measure was change in knowledge and
attitudes/intentions. Secondary outcomes were change in BMI, weight, systolic and
diastolic blood pressure, pulse, waist circumference, hope and clinician rating of clinical
status. Thirty-four participants with mental illness participated in an intensive 10-week
manualized group wellness program while the control group contained 31 participants
who did not receive the treatment.
Vreeland et al. (2010) found statistically significant pre-post improvement in
knowledge (p= 0.001), attitudes (p= 0.007), BMI (p= 0.0066), weight (p= 0.0079) and
systolic blood pressure (p= 0.0007). The study also found that the intervention group
evidenced statistically significant improvements in knowledge about and
attitudes/intentions toward making healthier lifestyle choices, weight, and BMI in
comparison to the group that did not receive any intervention. The study concluded that
an educational intervention may increase mental health consumers’ knowledge about
wellness and bring about changes in attitudes/intentions to pursue healthier lifestyle
choices. The relatively short study duration and lack of randomization of participants
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were recognized as limitations of this study. What is encouraging is that even a 10 week
psychoeducation intervention attained a clinically significant outcome for participants.
Menza et al. (2004) carried out a prospective study with the purpose of testing the
feasibility and efficacy of a multimodal weight control program for overweight and obese
mentally ill adults who had gained weight while taking atypical antipsychotic
medications. The participants were 31 subjects with schizophrenia or schizoaffective
disorder (DSM-IV), taking an atypical antipsychotic, who participated in a 52-week
Healthy Living program. The program incorporated nutrition counseling, exercise, and a
behavioral intervention designed to help adults with schizophrenia implement healthy
lifestyle changes. Strategies used in the program included behavioral strategies,
brainstorming, positive feedback and special teaching approaches. A group receiving
usual care contained 20 subjects. The primary outcomes which were measured in the
intervention group included BMI and weight while secondary outcomes included
hemoglobin A1c level, systolic and diastolic blood pressure, and cholesterol level
compared from baseline to endpoint (Menza et al., 2004). Twenty of the 31 subjects
completed the program. The study found statistically significant pre-post improvements
in weight (p<0.02), BMI (p< 0.02), hemoglobin A1c (p< 0.01), diastolic (p< 0.001) and
systolic (p< 0.05) blood pressure, exercise level (p< 0.003), nutrition knowledge (p<
0.0001), stage of change (exercise p< 0.0001), and weight (p< 0.008) in the intervention
group. Weight and BMI decreased significantly (p= 0.01) in the intervention group
compared with the “usual care” group, who gained weight.
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The study concluded that individuals with schizophrenia and schizoaffective
disorders benefited from a weight control program that focused on nutrition, exercise, and
motivation. Additionally the program resulted in clinically significant reductions in
weight, BMI, and other risk factors for long-term poor health, including hemoglobin A1c.
Lack of random assignment and a small sample size were identified as study limitations.
A key inference from this study is that a non-pharmacological intervention can lead to
weight loss and also improve other risk factors for poor health compared to no
intervention in clients with mental illness.
Brown and Chan (2006) carried out a randomized controlled trial using the Lilly
“Meaningful Day” manual which delivers health promotion interventions and focuses on
weight reduction. The Meaningful Day manual uses techniques such as motivational
interviewing, health education, and food and activity diaries among the interventions. It
also facilitates access to local community facilities. A total of 28 patients were
randomized to treatment (n= 15) or control (n= 13) group. Only 7 (47%) subjects and 10
(77%) controls completed the study. The mean change in weight between the subjects (0.40 kg weight loss) and controls (+ 1.11kg weight gain) was statistically significant, p=
0.01. The mean change in BMI between the subject (- 0.02 kg/m2) and the controls (+
0.41 kg /m2) was also statistically significant, p= 0.02. The study concluded that the
intervention produced significant health gains to participants. However the findings of
this study should be treated with caution due to the high attrition rate.
Another study carried out an electronic search of published articles pertaining to
the use of behavioral interventions in individuals with schizophrenia using PsyINFO and
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Medline (Loh, Meyer, & Leckband, 2006). A total of 23 studies with a total sample of
701 participants was identified. The types of behavioral interventions consisted of
behavioral modification techniques, caloric restriction, and psychoeducation. Weight
loss was reported in 19 studies, while the remaining studies showed either maintenance of
baseline weight or minimum weight gain. The authors concluded that much of the
literature was methodologically unsound and only applicable to inpatient settings.
Furthermore high drop-out rates and the absence of extended post-treatment follow-up
still limit the conclusions regarding general efficacy of behavioral treatment of obesity in
patients with schizophrenia.
Literature Review on Cognitive Behavioral Interventions
Three articles involving the use of cognitive behavioral interventions were
identified. Zhang et al. (2012) carried out a study to compare the effectiveness of a
cognitive-behavioral weight loss intervention in obese subjects with psychiatric disorders
and those without. This study was a 12 month naturalistic study of weekly group or
individual cognitive-behavioral management in 222 obese patients with psychotic
spectrum disorders (n=47), other psychiatric disorders (n= 49), and no psychiatric
disorders (n=126). Participants were either self-referred or referred by other health care
professionals. The mean age of the participants was 49.2 ± 14.1 years old and the mean
BMI was 43.7± 9.6. The treatment consisted of cognitive behavior therapy from
Northwestern University Medical School’s People at Risk Weight Control Program.
Weekly treatment was delivered by a team consisting of psychotherapist, a nutritionist,
and an exercise physiologist in individual sessions lasting 45 to 50 minutes or group
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sessions lasting 60 to 75 minutes. The assignment of group or individual treatment was
based on clinical judgment or patient’s preference. The treatment provided enhanced
self-monitoring of food intake and exercise habits, behavioral contracting, cognitive
restructuring, and stimulus control.
The primary outcome measure in the study by Zhang et al. (2012) was the
absolute and relative change in weight and BMI. Secondary outcomes included
percentage of patient with 5% or more weight loss at the end of treatment. The study
found that at the 12 month follow up, 62 patients (27.9%) remained in treatment. The
entire sample lost 3.54 ± 9.02 pounds from baseline (i.e. 1.34%± 3.39% loss ) of baseline
weight at the 3month follow up, 6.27 ± 14.62 pounds (2.33% ± 5.22%) at 6 months, 7.98
± 17.21 pounds (2.96% ± 6.23%) at 9 months , and 8.47 ± 18.75 pounds ( 3.15% ±
6.70%) pounds at 12 months (p< 0.001). Patients with a psychotic spectrum disorder had
greater percent baseline weight loss at 12 months (5.1% ± 9.3%) than patients with other
psychiatric disorders and with no psychiatric disorder (2.7% ± 5.5% and 2.4 ±6.3%).
Patients with psychotic spectrum disorder also had a greater percent BMI loss at 9
months (2.1 ± 3.5 kg/m2) and 12 months (2.3 ± 4.1 kg/m2) than those with no psychiatric
disorder (1.1 ± 2.3 and 1.2 ± 2.4 kg/m2) respectively. Weight loss of 5% or more
occurred in 42.6% of patients with psychotic spectrum disorders versus 18.4% and 23.0%
for those with other psychiatric disorders or with no psychiatric disorder (p< 0.001)
respectively. The study found that attrition was higher for those with no psychiatric
disorder (p = 0.001) or with other psychiatric disorders (p=0.036), for those who
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participated in a lower proportion of group sessions (p=0.002), for those with more
depression (p=0.028), and those with lower baseline BMI (p=0.030).
Zhang et al. (2012) concluded that patients with psychotic spectrum disorders had
greater weight loss than other obese patients. They also concluded that nonadherence and
depression should be targeted to enhance weight loss success. This study is significant as
it is the first study to compare weight loss outcomes of a non-pharmacological treatment
programs between patients with psychotic disorders and individuals with nonpsychotic
psychiatric conditions or no psychiatric illness. The authors identified study limitations
as lack of randomization, the lack of blinding, and the possibility that patients with
psychotic spectrum disorders received more clinical attention that resulted in them
staying in the program longer and in turn playing a role in their greater weight loss.
Weber and Wyne (2006) conducted a 16-week pilot study using a randomizedcontrol group design to examine the effectiveness of a cognitive behavioral group
intervention based on the Diabetes Prevention Project (DPP) lifestyle intervention for
individuals who were taking atypical antipsychotics. The study included people with
schizophrenia or schizoaffective disorder who were being treated in a large urban public
mental health clinic system. The content of the program was based on cognitive
behavioral strategies to promote risk reduction that were demonstrated to be successful in
the DPP. A total of 17 participants were randomized to either the 16 week cognitive
behavioral group intervention (n= 8) or treatment as usual group (n =9). The cognitive
behavioral group participants lost an average of 5.4 lb or 2.9% of body weight, and those
in the control group lost 1.3 lb or 0.6% body weight (Weber & Wyne, 2006). The range
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of weight loss for the treatment group was from 1 to 20 lbs. The researchers concluded
that the pilot study demonstrated that weight loss is possible with cognitive behavioral
interventions in a population with psychotic disorders. The major limitation of the pilot
study was the small sample size that made it impossible to show significance.
Kwon et al. (2006) carried out a study with the objective of assessing the efficacy
of a weight management program designed for outpatients taking olanzapine for
schizophrenia or schizoaffective disorder. The main components of the study were diet
and exercise management, which were based on cognitive and behavioral therapy. A
total of 48 patients were enrolled in a 12-week, randomized, multicenter weight
management study. A total of 33 patients were randomly assigned to the intervention
group which received olanzapine within a weight management program. Fifteen patients
were allocated to a control group in which they were given olanzapine treatment as usual.
Weight, body mass index (BMI), and measurements of safety and quality of life were
evaluated. A total of 36 patients (75%) in the intervention and the control group
completed the study. The study found a significant difference in weight (-3.94 ± 3.63 vs.
-1.48 ± 1.88 kg, p= 0.006) and BMI (-1.50 ± 1.34 vs. -0.59 ± 0.73, p= 0.007) change
from baseline to endpoint between the intervention and control groups respectively. The
study concluded that a cognitive behavioral weight management program was effective in
terms of weight reduction in patients with schizophrenia or schizoaffective disorder
taking olanzapine. The authors mention that the limitation of the study included a small
sample size and short study duration. Additionally, disproportionate dropout rate is a
limitation in the study; of the 36 patients who completed the study, 22 were in the
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intervention group, while 14 were in the control group. The strength of this study
includes the use of a comparison group and randomization of the participants.
Modes of Delivery of Educational Interventions
It is imperative that the design and content of educational program take into
account the strengths and limitations of the learners. Patients with mental illness may
have deficits in attention, memory, motor skills and social functioning. It is more
challenging to educate recipients of mental healthcare due to the cognitive impairments
associated with some psychiatric disorders, and due to the growing need for providing
greater information about the potential risks of some mental health treatments (Jeste,
Dunn, Folsom, & Zisook, 2008). Psychoeducational approaches have been developed to
increase patients’ knowledge of, and insight into, their illness and its treatment (Xia,
Merinder, & Belgamwar, 2011). It is expected that this increased knowledge and insight
will enable clients to cope in a more effective way with their illness, thereby improving
their prognosis.
Xia et al. (2011) searched the Cochrane Schizophrenia Group Trials Register.
Their objective was to assess the effects of psychoeducational interventions compared
with standard methods of knowledge provision. The selection criteria included all
relevant RCTs focusing on psychoeducation and /or related serious mental illness
involving individuals or groups. Quasi-randomized trials were excluded. A total of
5,142 participants from 44 trials conducted between 1988 and 2009 were included. The
median study duration was 12 weeks. The studies found that incidences of noncompliance were lower in the psychoeducation groups in the short term (n=1400, RR
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0.52 CI 0.40 to 0.67, NNT 11 CI 9 to 16). This finding held for the medium and long
term as well. Relapse appeared to be lower in psychoeducation groups (n =1214, RR
0.70 CI 0.61 to 0.81, NNT 9 CI 7 to 14). Furthermore data suggested that
psychoeducation promotes better social and global functioning. Further evidence
suggested that participants receiving psychoeducation were more likely to be satisfied
with mental health services (n=236, RR 0.24 CI 0.12 to 0.50, NNT 5 CI 5 to 8) and have
improved quality of life.
Various patient education interventions have been developed and can be used for
individuals with mental disorders. Fernandez, Evans, Griffiths, and Mostacchi (2006)
carried out a systematic review with an aim of investigating the efficacy of educational
interventions in relation to psychotropic medications for consumers with mental health
disorders. The review included RCTs that compared the effects of various educational
interventions on knowledge retention, compliance to medication and treatment, incidence
of relapse and insight into illness. Subjects were aged 18 years and over with mental
disorders. Structured information was defined as receiving information in a planned
manner (e.g., videotape, role-play, discussion) and the unstructured information consisted
of information that was delivered in an inconsistent manner (e.g., incidental teaching).
The study found that patients who were provided with education of either type
demonstrated a significant increase in the level of knowledge and compliance compared
with those who were not. A structured patient education using both written and verbal
methods followed by discussion of the contents proved effective in this patient
population. Further evidence also suggested that consumers who were provided with
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multiple education session had greater knowledge gains in the short term (up to 1 month);
however the effectiveness of multiple sessions in the long term (2 years) is inconclusive
in this patient group. The authors therefore concluded that the review provides evidence
that multiple education sessions are better than a single education session in improving
knowledge in relation to medications and insight into illness. Evidence from the trials
also demonstrated that structured educational interventions delivered at frequent intervals
are useful as part of the treatment programs for people with mental illness.
Pitkänen et al. (2012) carried out a study with the aim of estimating the
effectiveness of patient education methods on quality of life and functional impairment of
patients with schizophrenia. A total of 311 patients were randomly assigned to computerbased (information technology [IT]) patient education group (n=100), conventional
education with standard leaflets and discussions (n =106), and standard treatment
(n=105). In the IT education group, a patient participated in a systematic computer-based
education program (Mieli.Net) together with a nurse. The content covered information
on illness, treatment, well-being, support and patients’ right. In the conventional
education group patients received information in written leaflets. At the beginning of
each session the patients received an information leaflet on the topic and discussion
focused on that information. The average length of the patient education sessions was 30
minutes. In the standard treatment group patients received patient education according to
usual ward procedures. In Finland patient education varies between hospital and units,
there are no standardized and uniform guidelines. Depending on individual nurses’ own
motivation and inclination, patients may receive individual oral information on their
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illness and its treatment in care meetings. The patient in the standard treatment may have
also received written material. Nevertheless, educational activities were less systematic
and varied between study wards and shifts in the standard treatment group.
Participants in the study were followed up 12 months later. The primary outcome
was quality of life while secondary outcome was functional disability. The study found
that patients’ global quality of life improved and functional disability decreased
significantly in all education groups. Therefore there were no significant differences
between groups in these outcomes. The study concluded that there is no evidence to
support a particular education method as the best way to improve patient’s quality of life
or improve functional ability. The study also concluded that computer-based patient
education remains a suitable alternative for some patients. Study limitation includes a
high dropout rate of 27.7%. Strength of the study includes randomization of participants
to different education groups.
Jeste, Dunn, Folsom, and Zisook (2008) reviewed studies that compared the
effects of multimedia (video-or computer based) educational aids with those of routine
procedures to inform healthcare consumers about medical evaluations or management.
Most of the investigations were conducted for non-psychiatric patients. They found that
there are still very few studies concerning patient education programs that have been
developed and tested in clinical settings among patients with mental illness. A total of 37
RCTs trials were identified. Nearly two-thirds of the studies (n=23) reported that
multimedia educational aids produced better understanding of information compared to
routine methods which include pamphlets or leaflets. The authors concluded that
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multimedia educational aids hold promise for improving the provision of complex
medical information to patients and caregivers.
Recently Välimäki, Hatönen, Lahti, Kuosmanen, and Adams (2012) evaluated the
effects of psychoeducational interventions using information and communication
technology (ICT) as a means of educating and supporting people with schizophrenia or
related psychosis. They searched the Cochrane Schizophrenia Group Trials Register
(2008, 2009, and September 2010). They inspected references of identified studies for
further trials and contacted these authors for additional information. The selection
criteria were all RCTs comparing ICT as a psychoeducational and supportive tool with
any other type of psychoeducation and supportive intervention or standard care. They
included six trials with a total of 1063 participants. They found no significant differences
in the primary outcomes (patient compliance and global state) between
psychoeducational interventions using ICT and standard care.
Summary and Conclusion
The discussed literature review supports the use of a variety of interventions
rather than no intervention in management of weight in patients on antipsychotic
medications. What is encouraging is that even studies with small sample sizes attained a
meaningful outcome for participants that could improve their health outcomes. The
intervention that was implemented in the current project attempted to make a similar
effort by evaluating the effectiveness of an eight week psychoeducation intervention on
weight, BMI and other risks factors that predispose clients on antipsychotic medications
to prediabetes and diabetes. The intervention exposed the participants to an
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individualized multimedia psychoeducation with the emphasis on the role of eating and
exercises on weight management. The intervention also involved the use of structured
patient education using both written and verbal methods followed by discussion during
multiple education sessions as supported by the literature.
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CHAPTER 3
CONCEPTUAL FRAMEWORK

The purpose of this project was to implement a psychoeducational intervention
that would increase awareness of nutrition and physical activity for adults (aged 18 and
above) with severe mental illness who are taking antipsychotic medications. The second
purpose of the intervention was to determine if the intervention had any effect on weight,
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting
lifestyles among this group of adults. This chapter describes the Health Promotion Model
(HPM) that was used as a conceptualizing framework to direct the psychoeducation
intervention. The Chronic Care Model (CCM) was utilized to understand the
complexities of implementing the proposed project in a Community Mental Health Clinic
is also discussed.
Health Promotion Model
The HPM first appeared in nursing literature in 1982 and was revised in 1996
based on changing theoretical perspectives and empirical findings (Pender, Murdaugh, &
Parsons, 2006). The HPM model is shown in Figure 1. The HPM has its philosophical
roots in Reciprocal Interaction World View in which humans are viewed holistically, but
parts can be studied in the context of the whole. Human beings therefore interact with
their environment and shape it to meet their needs and goals. While implementing the
psychoeducational intervention, the facilitator understood that participants can be
successfully engaged in actions to achieve goals that are perceived as possible and that
can result in valued outcomes. Additionally the facilitator understood that to change

47

behavior, the participants had to change how they think. The main goal of the
psychoeducation intervention was therefore to influence participants to engage in health
promoting behaviors. The central focus of the model is on eight beliefs that can be
assessed and lead to the implementation of appropriate interventions.

Figure 1: Health Promotion Model. Adapted from The Health Promotion Model, Figure
2-4, p.50, Pender, Nola J.; Murdaugh, Carolyn L.; Parsons, Mary Ann. Health Promotion
in Nursing Practice, 5th edition, © (2006). Reprinted by permission of Pearson Education,
Inc, Upper Saddle River NJ. (See Appendix A)
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In total there are five key concepts in nursing defined as a basis for the HPM
(Pender et al., 2006). They include the person, environment, nursing, health and illness.
The person is considered to be a biopsychosocial organism that is partially shaped by the
environment but also seeks to create an environment in which natural and acquired
human potentials can be fully expressed (Pender et al., 2006). On the other hand the
environment is the social, cultural and physical context in which the life course unfolds.
The person does not live in isolation but interacts with the environment. Persons on
antipsychotic medications are predisposed to overweight and obesity as a result of
medication effects and individual characteristics. It has also been found that social and
cultural factors further influences their risk to weight gain. While using HPM during the
intervention, the facilitator viewed the participants holistically with the belief that they
have the ability to transform their environment by using strategies that were acquired
from the pyschoeducational sessions. The goal was to assist the participants to acquire
targeted health behaviors that would lead to an overall improvement of their physical
health.
Nursing is defined as collaboration with individuals, families, and communities
to create the most favorable conditions for the expression of optimal health and highlevel well-being (Pender et al., 2006). During the intervention the facilitator collaborated
with the participants and a community in a mid-western city in the United States with the
goal of improving the health outcomes of clients on antipsychotic medications.
Health in reference to the individual is the actualization of inherent and acquired
human potential through goal-oriented behavior, competent self-care, and satisfying
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relationships with others (Pender et al, 2006). The facilitator understood that the
psychoeducational intervention was aimed at influencing health promoting behaviors in
participants with the goal of improving participants’ physical health outcomes.
Pender et al. (2006) identify illnesses as discrete events throughout the life span.
Illness can be either of short (acute) or long (chronic) duration that can hinder or facilitate
one’s continuing quest for health. Overweight and obesity are a chronic conditions that
has been determined to be a threat to the well-being of persons on antipsychotic
medications. While using the HPM as a guiding framework for the intervention, the goal
of the facilitator was to prevent weight gain, a major threat that faces clients on
antipsychotic medications. The key to improving high rates of overweight and obesity of
this population is targeting lifestyle factors. Furthermore engaging in health promotion
initiatives was a key role of the facilitator.
Components of Health Promotion Model
Individual Characteristics and Experiences
Individual characteristics and experiences include prior related behavior and
personal factors (Pender et al., 2006). The facilitator acknowledged that these two factors
might influence individual’s health-promoting choices. The facilitator used a holistic
approach while assisting participants to formulate a plan of action. During the
intervention the facilitator obtained an initial assessment of reported daily intake of cups
of fruits and vegetables and reported weekly participation in physical activity. Other
characteristics of the participants that influenced health behavior that were obtained
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during the intervention included gender, ethnicity, age, weight, height, blood pressure,
pulse, waist and hip measurements and calculated BMI and waist/hip ratio.
Behavior-Specific Cognition and Affect
Behavior-specific cognition and affect that were targeted during the intervention
included (a) perceived benefits of action; (b) perceived barriers to action; (c)
interpersonal influences; (d) situational influences; and (e) commitment to a plan of
action. The facilitator understood that assisting participants to identify behavior-specific
cognitions and affect would facilitate self-efficacy in participants and enhance the ability
to perform the required action.
Perceived benefits of action are perceptions of the positive or reinforcing
consequences of undertaking a health behavior (Pender et al., 2006). During the
intervention, each participant was asked to identify at least three benefits of eating fruits
and vegetables daily. Additionally, participants also identified at least three benefits of
participating in at least 30 minutes of moderate-physical activity on most days of the
week.
Perceived barriers to action are the perceptions of the constraints and personal
costs of undertaking a health behavior (Pender et al., 2006). During the intervention
participants identified barriers that prevented them from eating more fruits, vegetables
and engaging in physical activity.
Interpersonal influences include family, peer and providers (Pender et al., 2006).
Interpersonal influences have been cited to provide norms, social support, role model
perceptions concerning the behaviors, beliefs, or attitudes of relevant others in regard to

51

engaging in a specific health behavior. The role of the facilitator during the intervention
was to provide education and support to participants with the aim of influencing
participants to eat more fruits, vegetables and engage in physical activity. The facilitator
also provided positive social support with the aim of influencing health promoting
behavior change.
Situational influences include options, demand characteristics and aesthetics
(Pender et al., 2006). The situational influence serves to support the perceptions of the
compatibility of life context or the environment with engaging in a specific health
behavior. Situational factors that affected the participants’ ability to attain predetermined
goals included access to fruits and vegetables. Situational influences also affected the
ability of the participants to meet their physical activity goals. During the intervention
the facilitator utilized multiple supported follow-up to reinforce positive behavior and
attainment of goals. Participants were also assisted in revising their goals when needed.
Commitment to a plan of action is the intention to carry out a particular health
behavior including the identification of specific strategies to do so successfully (Pender et
al., 2006). The identification of perceived benefits and barriers by participants enabled
them to set goals related to their fruit and vegetable intake and engage in physical
activity. While participating in the intervention each participant set a personal goal that
would assist them towards eating more fruits and vegetables. Participants also set a
second goal that assisted them towards participating in 30 minutes of moderate physical
activity on most days of the week. The supported follow-up and multiple sessions
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offered by the facilitator were intended to reinforce positive behavior and promote
adherence to goals.
Behavior Outcome-Health Promoting Behavior
According to Pender et al. (2006) the health promoting behavior is the desired
behavioral end point or outcome of health decision making and preparation to action.
The psychoeducation intervention emphasized that participants work towards eating
recommended amount of cups of fruits and vegetables per day and participate in at least
30 minutes of physical activity most days of the week by setting individual goals. It was
believed that when participants defined their goals, it assisted them to identify a plan that
could lead them to change their behavior. Additionally, health-promoting lifestyle
activities beyond dietary intake were assessed as an outcome.
Summary
The HPM was selected as the conceptual framework for the psychoeducation
intervention as it identifies contextual factors that influence health behavior. Further, the
model facilitated identification of components of the intervention.
The Chronic Care Model
The CCM was utilized to institute change during the implementation of the
proposed project (Wagner, 1998). The CCM is an evidence-based initiative developed
with the aim of reducing the gap between scientific advances regarding the prevention,
diagnosis, monitoring and treatment of chronic diseases and subsequent health outcomes
for patients. The CCM was developed for use in primary care, but it has been applied to

53

a variety of healthcare settings and targeted populations. The CCM model is shown in
Appendix B.
The CCM was used to assess the project site prior to the implementation of the
proposed intervention. The CCM focuses on interventions on six main components of
care that include community resources and policies, healthcare organizations, selfmanagement support, delivery system design, decision support, and clinical information
systems. These elements are designed to work together to strengthen the provider-patient
relationship and improve health outcomes. The aim of the CCM is to transform the daily
care for patients with chronic illnesses from acute and reactive to proactive, planned, and
population-based. At the core of this model are improved functional and clinical
outcomes for patients’ disease management resulting from productive interactions
between informed, activated patients and prepared, proactive teams of healthcare
professionals.
Components of Chronic Care Model
Community Resources and Policy
The role of the community is to mobilize resources to meet needs of patients by
encouraging patients to participate in effective community programs (Wagner, 1998).
One way to achieve this goal is by forming partnerships with community organizations to
support and develop interventions that fill gaps in needed services. Additionally the
community should also advocate for policies to improve patient care. It was also
important for the facilitator to assist participants in identifying resources in their
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communities that would enable them to increase fruit and vegetable intake and participate
in physical activity.
Health Care Systems
The health care system is the organization desiring to implement the CCM
(Wagner, 1998). The goal of CCM is to create a culture for organizations to promote
safe, high quality care. A system seeking to improve chronic illness must be motivated
and prepared for change throughout the organization. It was therefore necessary to assess
the organization’s perception of the proposed intervention and determine if the
organization was motivated to change. It was also imperative to assess if the
organization had the staff to sustain the intervention post its completion.
During the implementation of the project support from senior leadership was
necessary. The facilitator of the project collaborated with the team leader for the Case
Managers and the Case Managers in order to have the necessary support to implement the
intervention. During the intervention at the Community Mental Health Clinic in a midwestern city in the United States, the facilitator utilized the case managers as a resource
to encourage clients to participate in this psychoeducational intervention that might
improve their health outcomes. The facilitator also shared the findings of the project with
the leadership team of the Community Case Management after the completion of the
project.
Self-Management Support
This is a key component of the CCM designed to empower and prepare patients to
manage their health and health care (Wagner, 1998). To accomplish this goal during the
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intervention strategies that were utilized by the facilitator included (a) assessment, (b)
goal-setting, (c) action planning, (d) problem solving, (d) utilization of a placemat as a
cue to remind participants to engage in health promoting behaviors, and (e) support and
follow-up. Through these strategies, the facilitator formed a partnership with the
participants that enhanced a collaborative approach.
Delivery Systems Design and Decision Supports
The role of the delivery system design is to assure the delivery of effective,
efficient clinical care and self-management support (Wagner, 1998). Defining roles of
team members ensures the provision of evidenced-based care. Complex patients may
need more intensive management (care or case management) to optimize clinical care and
self-management. The role of case managers was to identify participants that would
benefit from the proposed pyschoeducational intervention. During the intervention,
participants received reminder phone calls from the facilitator and the case managers to
remind them of appointments. At the study site, clients are usually assisted with bus
tokens if they are in need of transportation. Case Managers assisted the participants with
bus tokens if needed. The team leader for the Case Managers provided logistic supports.
A good example was the assignment of a research room where the intervention was
implemented. Additionally, an agency laptop was provided to the facilitator to use for
data collection and storage during the intervention.
Clinical Information Systems
The role of clinical information systems is to organize patient and population data
to facilitate improvement of patient care (Wagner, 1998). Ortiz (2006) indicates that
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registries can be established without the availability of an electronic health record (EHR)
with the use of common software tools such as Excel. The facilitator utilized an Excel
spreadsheet for data collection. The project site uses CareLogic as the EHR. CareLogic
is a comprehensive flexible clinical, administrative and financial management system
designed specifically for behavioral health professionals for meaningful use. During the
intervention, secondary data that were abstracted from the site’s EHR included
participants’ diagnoses and medications. During the project, the intervention and the
outcomes were not documented in the agency’s EHR.
Summary
The CCM was selected as it provided a conceptual framework to explore the
complexities of implementing a psychoeducational intervention project in a Community
Mental Health Clinic. The CCM assisted the facilitator of the intervention to engage the
organization’s leadership and staff members to support the success of the
implementation. The CCM also enabled the identification and utilization of agency’s
resources to enhance the implementation. More importantly, the CCM assisted the
facilitator to understand how to engage individuals to make informed choices that could
lead to improved health outcomes.
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CHAPTER 4
METHODS

The purpose of this project was to implement a psychoeducational intervention
that would increase awareness of nutrition and physical activity for adults (aged 18 and
above) with severe mental illness who are taking antipsychotic medications. The second
purpose of the intervention was to determine if the intervention had any effect on weight,
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting
lifestyles among this group of adults.
This chapter describes the methods and strategies that were utilized to develop
and implement a psychoeducational intervention in adults on antipsychotic medications at
a Community Mental Health Clinic in a mid-western city in the United States. The
project was conceptualized in four phases (a) development of the intervention; (b)
assessment of the project implementation site; (c) implementation of the psychoeducation
interventions; and (d) analysis of outcomes of the intervention. After receiving approval
from Human Research Review Committee, Grand Valley State University (Appendix C)
and from the Mental Health agency (Appendix D), participants were recruited by method
of referrals from case managers. The participants in the project were English speaking
and were referred by the case managers from the Case Management case load. Another
inclusion criterion was a participant must be taking at least one antipsychotic medication.
An exclusion criterion was any patient determined to be acutely mentally ill. This is
because psychoeducation is not considered an appropriate intervention in the acute phase
of illness.
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Study Site
The intervention was carried out at a Community Mental Health Clinic in a midwestern city in the United States in the Spring of 2014. Many of the clients served by
this clinic are poor, homeless, or uninsured. The mental illnesses range from
schizophrenia and bipolar disorder to anxiety disorder. These clients generally have
difficulty accessing health care. Issues like alcohol abuse and drug use are also prevalent
among this population. Financial difficulties were a potential barrier for participants to
meet project goals. The challenges included lack of transportation and access to fruits and
vegetables.
Site Population
The number of mental health clients in Spring 2014 served under the Case
Management caseload consisted of 266 clients. Of the 266 clients, 135 clients (50.8%)
are male, 126 clients (47.4%) female, and 5 clients (1.9%) have unknown gender. The
ethnicity represented include 2 clients (0.8%) Native American, 57 clients (21.4%)
Black, 20 clients (7.5%) Hispanic, 160 clients (60.2%) White, 3 clients (1.1%)
Korean/Asian, 7 clients (2.6%) two or more races and 17 clients (6.4%) have their
ethnicity unreported. The age representation included 60 clients (22.6%) age range 1829, 205 clients (77.1%) age range 30-64, and 1 client (0.4%) over age 64.
Project Sample
A total of 23 participants were recruited for this project (Table 1). The sample had
more males than females. Over half of the participants were White in ethnicity. The
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minimum age was 25 and the maximum age was 55. The mean age for the participants
was 44.96. All the 23 participants completed session 1.
Table 1
Demographic Characteristics of Participants
________________________________________________________________________

Characteristics

Participants who were recruited
for the intervention (n=23)
__________________________

Participants who completed
the intervention (n=19)
_______________________

n
%
n
%
________________________________________________________________________
Race
White/Caucasian

12

52.2

10

52.6

Black/African American

9

39.1

7

36.8

Hispanic

1

4.3

1

5.3

Native American

1

4.3

1

5.3

15

65.2

12

63.1

8

34.8

7

36.8

25-35 years

2

8.6

2

10.5

36-45 years

8

34.4

7

36.8

46 - 55 years

13

55.9

10

52.8

Gender
Male
Female
Age in Years

________________________________________________________________________
A total of 21 participants, 14 males and 7 females, completed session 2 after
which two participants dropped out. A total of 19 participants (82.6%), 12 males and 7
females completed both session 3 and 4, therefore completing the entire
psychoeducational intervention. The demographic information for the 19 participants
who completed the entire pyschoeducation intervention is also presented in Table 1. The
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common psychiatric diagnoses among the participants included major depressive
disorder, bipolar disorder, schizo-affective spectrum disorders, psychotic disorders,
anxiety disorders, dissociative somatoform disorders, and substance use disorders.
After the first session one white female participant voluntarily dropped out stating
she was no longer interested in the intervention. The second participant to stop after
completing session 1 was a White/Caucasian male participant who did not provide a
reason of why he stopped the project. The third drop out was a male Black/African
American participant, who cited transportation issues as the reason that he was unable to
complete. The fourth male Black/African American participant stopped participating
without providing a reason. His phone went unanswered when contacted to remind him
of follow-up sessions. The final characteristics of the participants who completed the
intervention (n=19) is similar to the original recruited group of participants. The majority
of the sample were over the age of 30, similar to the population that receives services at
the agency.
Procedures for Recruitment
Recruitment and Informed Consent
After receiving approval from Human Research Review Committee Grand Valley
State University and the Mental Health Agency, participants were recruited by method of
referrals from case managers at the Agency. While clients were visiting their case
managers during the months of April - June 2014, case managers used a recruitment
script (Appendix E) to recruit potential participants for the intervention. The script
introduced the DNP student who was the facilitator of the intervention. Additionally the
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script gave an outline of the intervention including the (a) number of sessions, (b)
duration of the intervention, (c) length of the sessions, (d) measures to be obtained, and
(e) the purpose of the intervention. The participants who were interested and had been
referred to participate in the study were provided with an informed consent form
(Appendix F) after receiving a complete description of the study. The informed consent
form incorporated language of the Health Insurance Portability and Accountability Act
(HIPAA) to assure the confidentiality of participant data. The DNP student obtained the
informed consent, while the agency supervisor came in immediately afterwards to answer
questions and concerns from participants and to confirm their understanding of the
project before signing off on the informed consent. Participants then received a copy of
the signed informed consent.
The informed consent included information about the risks, benefits, costs and
compensation of participation in the project. Participants were informed that the risks of
participation in the project included loss of confidentiality. Participants were notified
that to ensure that their information is protected, their data were stored in an encrypted
manner. The data collection documents were also coded to keep each participant’s data
together and the list of codes were destroyed when data collection was complete.
Documents were kept in a locked secure location and will be destroyed three years after
data collection.
Project Procedure
Following consent, initial data were gathered. These consisted of HealthPromoting Lifestyle Profile II questionnaire and anthropometric data. The program
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consisted of four, 45 minute sessions implemented over eight weeks. The first session
was primarily educational and planning. At the start of the second and third session
participants received supportive follow-up for the previous educational sessions. Progress
toward the attainment of previous goals was also evaluated. Additionally, if needed, the
goals were revised. Participants also received phone calls as a reminder to attend their
session.
After completing each individualized session, participants were verbally reminded
when they should return for the next session. A phone call reminder was placed to
participants the day before their session to remind them of their appointment. Some
participants still had to be called on the day of the intervention if they were late for their
appointment or if their phones were not answered or working on the previous day.
Data Collection
In this project, participants were weighed on the same scale without shoes. The
facilitator of the intervention was responsible for obtaining all the anthropometric
measurements. In this project, data that were obtained at the first session included
gender, ethnicity, age, weight, height, blood pressure,pulse, waist size, hip size,
calculated BMI, waist/hip ratio, intensity of physical activity and fruit and vegetable
intake. BMI was calculated using height measured at baseline and weight obtained at
each session. The National Heart Lung and Blood Institute’s BMI was used to categorize
patients. A BMI of 18.5-24.9 was categorized as normal, BMI 25-29.9 was considered
overweight, while a BMI of 30 or greater was considered obese. Additionally the HealthPromoting Lifestyle Profile II questionnaire was completed at the first and the last
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sessions. During the second, third and fourth sessions, data that were obtained included
weight, blood pressure, pulse, waist size, hip size, calculated BMI, waist/hip ratio and
intensity of physical activity. Secondary information was obtained by reviewing patients’
charts to obtain information on patient diagnoses, names and doses of prescribed
antipsychotic medications. Data were recorded on a participant data collection sheet
(Appendix G) during the project.
Instrument
The Health-Promoting Lifestyle Profile II (Appendix H) measures behavior
associated with health-promoting lifestyles. This instrument was utilized during the first
and fourth session. The tool has 52 items and the format is a four point response scale:
never, sometimes, often, and routinely and can be self-administered (Walker & HillPolerecky, 2011). The instrument is scored by calculating the mean of individual
responses to all 52 items. The six subscales scores are similarly obtained by calculating a
mean of the individual’s response to subscale items. The questions in the instrument are
scored as follows: 1=never, 2=sometimes, 3=often and 4=routinely. The higher the
score, the greater the improvement. The Health-Promoting Lifestyle Profile (HPLP) II
has six subscales which include spiritual growth, interpersonal relations, nutrition,
physical activity, health responsibility and stress management. Spiritual growth involves
the sharing of thoughts and feelings through verbal and nonverbal messages. The
interpersonal relations scale involves utilizing communication to achieve a sense of
intimacy and closeness within meaningful, rather than more casual, relationships with
others. Nutrition involves knowledgeable selection and consumption of foods essential
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for sustenance, health, and well- being. Physical activity involves regular participation in
light, moderate, and/or vigorous activity. Health responsibility involves an active sense
of accountability for one’s own well-being. It includes paying attention to one’s own
health, educating oneself about health, and exercising informed consumerism when
seeking professional assistance. Stress management entails the identification and
mobilization of psychological and physical resources to effectively control or reduce
tension.
Walker and Hill-Polerecky (2011) calculated the test-retest reliability of the
Health-Promoting Lifestyle Profile II as 0.892 after a three week interval. They reported
the internal consistency as Cronbach’s alpha 0.943, while the subscales range from
0.793-0.872. In this project, the Chronbach’s alphas are displayed in Table 2 and are
consistent with the prior reliabilities except for two subscales. The nutrition subscale and
interpersonal relationship subscale obtained at both data collection points were lower
than reported by the original authors.
Walker and Hill-Polerecky (2011), performed several validity measures. The
construct validity was confirmed by factor analysis. Factor analysis confirmed the sixdimensional structure of HPLP II. Further, construct validity of the tool was supported
by convergence with the Personal Lifestyle Questionnaire (r = 0.678), and by a nonsignificant correlation with social desirability. The HPLP II has significant criterion
validity with concurrent measures of perceived health status and quality of life (r = 0.269
-0.491).
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Table 2
Chronbach’s Alpha Reliability Scores for the HPLP II
________________________________________________________________________
Cronbach’s Alpha
Cronbach’s Alpha
Pre-intervention
Post-intervention
(n=23)
(n=19)
________________________________________________________________________
Scale

HPLP 52 item scale

0.921

0.935

Health responsibility

0.739

0.849

Physical Activity

0.833

0.743

Nutrition

0.789

0.448

Spiritual Growth

0.714

0.739

Interpersonal Relationship

0.329

0.614

Stress Management

0.810

0.728

________________________________________________________________________
Intervention
The project consisted of four individualized, 45 minute psychoeducational
sessions implemented over eight weeks. The participants were seen at baseline, day 1620, day 34-38 and day 52-56. The participants participated in the intervention between
the months of April to July 2014. The facilitator utilized a psychoeducational project
implementation manual which outlined the session contents. Two sources of information
were used to develop the pyschoeducation intervention. The first source was the
Supplemental Nutrition Assistance Program (SNAP) Nutrition Education and Obesity
Prevention Grant Program, referred to as SNAP-Ed (United States Department of
Agriculture [USDA], n.d). SNAP-Ed connection has an online resource center for state
and local SNAP-Ed providers. SNAP-Ed is funded by USDA Food and Nutrition
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Service. The second source was selected sessions from Eat Smart, Live Strong tool kit.
The tool kit has been designed for use among able-bodied, 60-74 year olds participating
in, or eligible for, Food and Nutrition Service (FNS) nutrition assistance programs and is
consistent with the 2010 Dietary Guidelines for Americans and MyPlate (USDA, 2013).
The tool kit was adapted for the selected population since it is tailored for low income
adults. Furthermore the recommended amount of fruit and vegetable intake for the study
population was readily adjusted using available online tools such as the SuperTracker
(USDA, n.d).
The sessions in the intervention stressed the importance of improving fruit and
vegetable consumption and physical activity. The intervention focused on two key
messages of the 2010 Dietary Guidelines for Americans (USDHHS & USDA, 2010) and
utilized a variety of behavior-focused strategies to promote these behaviors: (a) increase
fruit and vegetable intake by making half of your plate fruit and vegetable; (b) balance
calories with physical activity to sustain a healthy weight; and (c) participate in at least
30 minutes of physical activity most days of the week. The sessions were designed to
motivate and build skills in participants while utilizing self-assessment tools to assist
them in achieving eating and physical activity goals.
Session Content
The first session was titled “Reach Your Goals, Step by Step.” The purpose of
the first session was to encourage participants to eat more fruits and vegetables and to
participate in more physical activity. During the first session initial data and
measurements that included gender, ethnicity, age, weight, height, blood pressure, pulse,
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waist size, hip size, calculated BMI, waist/hip ratio, intensity of physical activity level
and fruit and vegetable intake were obtained (Appendix G). Additionally the HealthPromoting Lifestyle Profile II questionnaire was completed (Appendix H). Estimated
calorie needs of each participant was determined using estimated calorie need per day by
age, gender and physical activity table (Appendix I). The required amount of cups of
fruits and vegetables that each participant needed to consume was determined by the
facilitator using super tracker at every session. The super tracker is an online tool that
can help one plan, analyze and track diet and physical activity (USDA, n.d.).
The psychoeducation module in the first session included the benefits of eating
fruits and vegetables and participating in at least 30 minutes of moderate-physical activity
on most days of the week. During the session each participant identified three benefits of
eating the recommended amount of cups of fruits and vegetables daily. Each participant
also identified three benefits of participating in at least 30 minutes of moderate-physical
activity on most days of the week. All participants also listed ways in which they could
be physically active. The first session also encouraged behavior change by providing
participants with an opportunity to set goals and track achievement. Each participant set
a personal goal towards eating the recommended cups of fruits and vegetables until the
next session. Participants also set a second goal towards participating in 30 minutes of
moderate-physical activity on most days of the week until the next session. Each
participant received a copy of the goal setting handout (Appendix J) to monitor progress
of fruit and vegetable intake and physical activity levels. The participants were also
provided with measuring cups that they could use at home to measure their fruits and
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vegetables. Additionally a placemat to help participants monitor their portions was
provided to participants to take home. The placemat was illustrated with (a) one cup
measure of fruits and vegetables, (b) a reminder to engage in physical activity, and (c) my
plate logo (Appendix K). The placemat was also used as a cue to reinforce the teachings
in the intervention. Samples of one cup measured fruit and vegetables were exhibited to
participants during the session. A grant from Kirkhof College of Nursing, Vulnerable
Population Center of Distinction, supported the purchase of these and other items used
with the intervention.
The second session was titled “Challenges and Solutions.” At the start of the
session, the second set of measurements were obtained. The measurements included
weight, blood pressure, pulse, waist size, hip size, calculated BMI, waist/hip ratio,
intensity of physical activity level and fruit and vegetable intake. The second session was
designed to offer suggestions that are helpful in adapting eating and physical activity
behaviors that could assist participants to reach their goals. The session also encouraged
behavior change by building participants’ ability to overcome challenges. The facilitator
offered supportive follow-up at the beginning of the session to participants by evaluating
progress towards goal of fruit/vegetable intake and physical activity. If needed, the
facilitator also assisted the participant to set new goals.
The education module in the second session focused on barriers of eating fruits
and vegetables and participating in at least 30 minutes of moderate-physical activity on
most days of the week. Additionally the module discussed solutions to the barriers.
During the session, participants identified barriers that might prevent them from eating
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more fruits and vegetables, and engaging in physical activity. Participants also identified
three solutions to overcome the challenges they identified that prevented them from
eating more fruits and vegetables and exercising. The facilitator offered support and
necessary resources for overcoming the barriers as well as answered questions that any
participant had. Once more, each participant identified three benefits of eating the
recommended amount of cups of fruits and vegetables daily. Each participant also
identified three benefits of participating in at least 30 minutes of moderate-physical
activity on most days of the week again. For a second time, participants listed ways in
which they will be physically active. Again at this session each participant set a personal
goal towards eating the recommended cups of fruits and vegetables until the next session.
Participants also set a second goal towards participating in 30 minutes of moderatephysical activity on most days of the week until the next session.
The third session was referred to as “Colorful and Classic Favorites.” At the
start of the session measurements that were obtained included weight, blood pressure,
pulse, waist size, hip size, calculated BMI, waist/hip ratio, intensity of physical activity
level and fruit and vegetable intake. The facilitator offered supportive follow-up at the
beginning of the session to participants by evaluating progress towards goal of
fruit/vegetable intake and physical activity. If needed, the facilitator also assisted the
participant to set new goals. The education module in the third session consisted of a
word game (Appendix L, M) and coloring activity (Appendix N). During the word game
activity, the participant was able to review the lists of challenges and solutions for eating
recommended cups of fruits and vegetables each day and participating in physical
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activity. The participants were also exposed to hands-on experiences in updating classic
recipes by adding fruits and vegetables by coloring. An easy-to-make recipe was also
provided to help participants make a classic dish at home (Appendix O). Once more,
each participant identified three benefits of eating the recommend amount of cups of
fruits and vegetables daily. Each participant also identified three benefits of participating
in at least 30 minutes of moderate-physical activity on most days of the week again. For
a third time each participant listed ways in which they can be physically active. Each
participant set a personal goal towards eating the recommended cups of fruits and
vegetables until the next session. Participants also set a second goal towards participating
in 30 minutes of moderate-physical activity on most days of the week until the next
session.
The fourth session was the final session. The facilitator made a final assessment
in evaluating participant progress towards goals of fruit/vegetable intake and physical
activity. During the session post intervention measurements were obtained. These
measurements included weight, blood pressure, pulse, waist size, hip size, calculated
BMI, waist/hip ratio, intensity of physical activity and fruit and vegetable intake. The
Health-Promoting Lifestyle Profile II was also completed for a second time as a post-test.
During the session the facilitator discussed with the individual participants the goals and
the progress they made during the intervention. Participants were also encouraged to
continue with the lifestyle changes that were emphasized in the intervention. Each
participant set a personal goal towards eating the recommended cups of fruits and
vegetables after the completion of the intervention. Participants also set a second goal
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towards participating in 30 minutes of moderate-physical activity on most days of the
week after the completion of the intervention.
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CHAPTER 5
RESULTS

The purpose of this project was to implement a psychoeducational intervention
that would increase awareness of nutrition and physical activity for adults (aged 18 and
above) with severe mental illness who are taking antipsychotic medications. The second
purpose of the intervention was to determine if the intervention had any effect on weight,
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting
lifestyles among this group of adults. This chapter reports the key study outcomes. The
chapter also reflects responses from the participants to the Health-Promoting Lifestyle
Profile II questionnaire.
Fruit and Vegetable Intake
Results show that there was an increase in both fruit and vegetable intake among
the 19 participants who completed the study (Table 3). The mean of the fruit intake for
the 19 participants at the start of the program was 8.73 cups/2weeks and 20.31
cups/2weeks at the end of the program. A paired t-test found that the increased fruit
intake was statistically significant p = 0.001 (Table 3). Similarly, a paired sample t-test
comparing vegetable intake found that increased vegetable intake was statistically
significant p = 0.001. The vegetable intake was lower at the start of the program (mean=
15.85 cups/ 2 weeks) than at the end of the program (mean= 38.45 cups/ 2 weeks) among
the 19 participants (Table 3).
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Table 3
Paired Samples t-Test Results for Health-Related Behavioral Changes Reported for the Prior Two Weeks
____________________________________________________________________________________________________________
HPLP Scale

Group Means

SD

Mean difference

SD

t

df

p

____________________________________________________________________________________________________________
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Physical Activity Pre

172.10

160.81

Physical Activity Post

360.00

275.31

Vegetable Intake Pre

15.85

10.53

Vegetable Intake post

38.45

24.76

8.73

8.99

20.31

12.56

Fruit Intake pre
Fruit Post

-187.90

225.13

3.63

18

0.002*

-22.60

25.68

3.93

18

0.001*

-11.58

12.52

4.02

18

0.001*

____________________________________________________________________________________________________________
Note.* significant p value.

Physical Activity
Results show that there was an increase in time spent in physical activity among
the 19 participants who completed the study (Table 3). The mean of physical activity
minutes for the 19 participants at the start of the program was 172.10 minutes/2weeks
and 360.00 minutes/2 weeks at the end of the program. Paired sample t-test comparing
the time spent in physical activity before and after the intervention was significant (p =
0.002).
Weight and BMI
For the 19 participants who completed the project, the minimum weight at the
beginning of the intervention was 131 pounds while the maximum weight was 337
pounds. Table 4 show the weight characteristics for the 19 participants at the start and
the end of the program. Result show that overall, 12 (63%) participants who completed
the program lost weight over the 8 weeks of the intervention.

The range of weight loss

among these participants was 0.25 to 10 pounds. One participant maintained the pre
intervention weight while a total of 6 participants had an increase in their post
intervention weight. The mean of the weight for the 19 participants at the start of the
program was 221.46 pounds and 219.82 pounds at the end of the program. Despite the
weight loss by some participants, results of paired sample t-test comparing the weight
before and after the intervention was not significant p value = 0.184 (Table 5).
Of the 19 participants who completed the study, three (15.8%) had a normal BMI of
18.5-24.9, while four (21.5%) participants were overweight with a BMI 25-29.9 at the
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start of the intervention (Table 6). A total of 12 (63.1%) of the participants had a BMI of
30 or greater, therefore considered obese. These BMI cut off points are determined by the
Table 4
Weight at the Start and the End of the Intervention
________________________________________________________________________
Participant
Weight
Weight
ΔWeight
ID
at the start
at the end
_______________________________________________________________________
014

174.75

164.75

-10.00

012

239.00

231.00

- 8.00

006

169.25

161.75

-7.50

023

297.25

291.00

-6.25

021

140.00

134.00

-6.00

009

275.00

269.00

-6.00

011

248.00

243.75

-4.25

022

258.50

255.00

-3.50

004

131.00

129.00

-2.00

018

305.25

303.25

-2.00

017

197.50

197.00

-0.50

010

181.50

181.25

-0.25

020

166.00

166.00

0.00

007

150.50

151.25

+0.75

016

239.00

239.75

+0.75

015

198.25

202.25

+4.00

008

287.00

291.25

+4.25

019

337.00

343.25

+6.25

004

213.00

222.00

+ 9.00

________________________________________________________________________
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Table 5
Paired Sample t-Test for Biological Variables
_____________________________________________________________________________________________________________________
Item

Mean

SD

Mean Difference

SD

t

df

p

_____________________________________________________________________________________________________________________
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Weight pre

221.46

60.82

Weight post

219.82

61.96

BMI pre

33.13

9.27

BMI post

32.89

9.55

Waist pre

44.68

7.37

Waist post

44.04

7.68

Hip Pre

46.94

6.08

Hip Post

45.56

6.01

Waist: Hip pre

0.95

0.10

Waist: Hip post

0.96

0.10

Systolic BP pre

124.32

11.93

Systolic BP post

122.63

15.32

Diastolic BP pre

81.63

6.18

Diastolic BP post

82.26

8.84

Pulse pre

82.47

15.41

Pulse post

80.53

10.86

1.63

5.15

1.38

18

0.184

0.23

0.78

1.31

18

0.206

0.63

1.59

1.73

18

0.100

1.38

1.19

5.04

18

0.0001*

-0.01

0.03

-1.75

18

0.097

1.68

13.75

0.53

18

0.600

-0.63

7.96

-0.35

18

0.733

1.94

12.05

0.70

18

0.490

___________________________________________________________________________________________________________________

Note.* significant p value.

Table 6

BMI at the Start and the End of the Intervention
________________________________________________________________________
Participant
BMI
BMI
ΔBMI
ID
at the start
at the end
_______________________________________________________________________
014

27.37

26.00

-1.37

012

35.29

34.11

-1.18

021

22.59

21.63

-0.96

009

43.07

42.13

-0.94

023

38.16

37.36

-0.80

010

26.04

25.33

-0.71

006

26.51

25.80

-0.71

011

34.59

33.99

-0.60

022

34.10

33.64

-0.46

005

21.80

21.46

-0.34

018

40.27

40.00

-0.27

017

32.86

32.78

-0.08

020

28.49

28.49

0.00

007

20.99

21.09

+0.10

016

32.41

32.64

+0.23

015

31.99

32.51

+0.52

008

43.63

44.28

+0.65

019

59.69

60.84

+1.15

004

29.70

30.96

+1.26

________________________________________________________________________
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American Heart Association (2013). The mean of the BMI for the 19 participants at the
start of the program was 33.13, and 32.89 at the end of the program (Table 5). The paired
sample t-test comparing BMI before and post intervention also had a non-significant p
value = 0.206 (Table 5).
Waist Circumference, Hip Size and Waist/Hip Ratio
Waist circumference which is a measure of central adiposity is now considered to
be a more valid predictor for risks for cardiovascular disease, type 2 diabetes and other
metabolic risk-related conditions compared to BMI (National Institute of Health [NIH],
2011). Waist circumference greater than 35 inches for women and 40 inches for men is
indicative of increased cardiometabolic risk (Jensen et al., 2013). A total of six (85.7%)
out of the seven women and nine (75%) of twelve males who completed the intervention
were above this cutoff at the start of the intervention (Table 7) indicating the group had
increased cardiometabolic risk. The mean for the waist circumference for the 19
participants at the start of the program was 44.68 and 44.05 at the end of the program
(Table 5).

A paired t-test comparing the waist circumference at the start and the end of

the intervention was statistically non-significant (p value = 0.184).
Hip circumference when used in conjunction with waist circumference facilitates
the measurement of central adiposity. For the 19 participants who completed the project,
a paired t-test found that hip size change had a statistically significant p value = 0.0001.
The hip size was lower at the end, mean=45.56 inches, than at the start of the
intervention, mean = 46.94 inches (Table 5).
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Table 7

Waist Circumference Before and After the Intervention by Gender and Descending
Change
________________________________________________________________________
Participant
Gender
Waist
Waist
ΔWaist
ID
at the start
at the end
________________________________________________________________________
022
male
49.01
45.87
-3.14
012

male

50.00

47.44

-2.56

004

male

45.00

47.64

-2.00

014

male

42.00

40.55

-1.45

010

male

37.00

35.63

-1.37

018

male

55.30

54.92

-0.38

009

male

53.00

52.56

-0.44

007

male

29.13

29.13

0.00

016

male

48.62

48.62

0.00

006

male

40.98

39.57

+1.41

023

male

48.80

47.83

+0.97

005

male

34.01

34.84

+0.83

021

female

32.48

28.74

-3.74

017

female

46.26

44.09

-2.17

011

female

45.98

45.47

-0.51

008

female

55.00

54.92

-0.08

015

female

46.26

47.64

+1.38

019

female

48.22

49.41

+1.19

020

female

41.93

42.04

+0.11

________________________________________________________________________
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Calculated waist-hip ratio (waist circumference divided by hip circumference) of
participants is shown in Table 8. Waist-hip ratio measures body fat distribution and has
Table 8
Waist-Hip Ratio Before and After the Intervention by Gender
________________________________________________________________________
Participant
Gender
Ratio
Ratio
ΔRatio
ID
at the start
at the end
________________________________________________________________________
022
male
0.99
0.94
-0.05
010

male

0.89

0.86

-0.03

009

male

1.02

1.00

-0.02

014

male

0.90

0.95

+0.05

007

male

0.72

0.77

+0.05

004

male

1.01

1.06

+0.05

016

male

1.07

1.10

+0.03

005

male

0.87

0.89

+0.02

018

male

1.08

1.10

+0.02

006

male

0.97

0.98

+0.01

023

male

0.96

0.97

+0.01

012

male

1.06

1.07

+0.01

021

female

0.83

0.77

-0.06

011

female

0.92

0.92

0.00

017

female

0.99

0.99

0.00

008

female

1.01

1.06

+0.05

015

female

1.08

1.11

+0.03

020

female

0.91

0.94

+0.03

019

female

0.75

0.79

+0.04

________________________________________________________________________
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been found to be better in determining visceral fat than BMI (Seidell et al., 1989). In
some studies waist-hip ratio has also been found to be positively associated with
incidence of myocardial infarction, stroke, and death from all causes in men and women
after adjusting for BMI (Larrson et al., 1984). Waist/hip ratio greater than 0.90 cm in
men and 0.85 cm in women is indicative of increased cardiometabolic risk (USDA,
1990). A total of five (71.4%) out of the seven women and eight (66.6%) of twelve
males who completed the intervention were above this cutoff at the recruitment (Table 8)
indicating the group had increased cardiometabolic risk. The mean of waist/hip ratio for
the 19 participants at the start of the intervention was 0.95, and 0.96 at the end of the
intervention (Table 5). A paired sample t-test comparing the waist/ hip ratio at the start
and the end of intervention was statistically non-significant with a p value of 0.97.
Systolic and Diastolic Blood Pressure
A total of three of the nineteen participants who completed the intervention had
blood pressure greater than 140/90, while two of the nineteen participants had blood
pressure greater than 130/85 at the start of the intervention. A blood pressure of 130/85
or higher is considered a metabolic risk factor (NIH, 2011). The mean for systolic blood
pressure for the 19 participants at the start of the program was 124.32 and 122.63 at the
end of the intervention. A paired t-test comparing the systolic blood pressure at the start
and the end of the intervention was statistically non-significant, p value = 0.600 (Table
5). The mean for diastolic blood pressure for the 19 participants at the start of the
program was 81.63 and 82.26 at the end of the program. Similarly, a paired t-test
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comparing the diastolic blood pressure at the start and the end of the intervention was
statistically non-significant, p value = 0.733 (Table 5)
Pulse
The mean for the pulse rate for the 19 participants at the start of the program was
82.47 and 80.53 at the end of the program (Table 5).

A paired t-test comparing the

pulse at the start and the end of the intervention was statistically non-significant, p value
= 0.490 (Table 5).
Results for Health-Promoting Lifestyle Profile II
The pre- and post- Health-Promoting Lifestyle Profile II questionnaire (Appendix
H) scores were analyzed using paired t-tests. Results for the paired sample t-test for
Health-Promoting Lifestyle Profile II are presented in Table 9. The paired t-test for the
52-item pre- intervention Lifestyle Profile II and post-intervention Lifestyle Profile II
was significant (p=0.026). The paired t-test for pre-intervention Physical Activity and
post-intervention Physical Activity subscale was also significant (p=0.044). Finally, the
paired t-test for pre-intervention Spiritual Growth and post-intervention Spiritual Growth
subscale was also significant (p = 0.012). All of these scales increased during the
intervention. No other subscales showed a significant change.
The items on the physical activity subscale include (a) following a planned
exercise program, (b) type and time spent in physical activity, (c) engaging in physical
activity as a form of recreation or daily activities, and (d) checking pulse and reaching
target heart rate when exercising. The items on spiritual growth include (a) changing in
positive ways, (b) life having a purpose, (c) looking forward to the future, (d) feeling
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content with self, (e) working toward long term goals, (f) exposing self to new
experiences and challenges, (g) finding one’s days interesting, (h) being aware of what is
important in life, and (i) feeling connected with a greater force.
Other Findings
Goal Setting and Participants
The goals that pertain to fruit and vegetable intake and physical activity for three
participants who lost the most weight and three who gained the most weight are presented
in Table 10. The goals of the participants who lost the most weight during the
intervention were generally consistent related to increasing the intake of fruits and
vegetables as well as physical activity. The majority of the participants who lost weight
at the end of the intervention indicated that they would engage in at least three days of 30
minutes or greater of physical activity for at least three days or more each week. Two
participants who planned to participate in seven days of physical activity after the first
session, as well as increase their intake of cups of fruits and vegetables, lost 7.5 pounds
and 10 pounds. At the end of the intervention, interestingly, the participant who had lost
10 pounds indicated that he would maintain physical activity at 30 minutes seven days a
week, but decrease his intake of fruit and vegetable to 1 cup daily.
The participants who gained the most weight also made relatively consistent goals
pertaining to their fruit and vegetable intake, and physical activity (Table 10). However, a
few of the participants also made inconsistent goals. After examining the goal setting of
all participants the consistency of goal setting had little impact on biological outcomes.
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Table 9
Paired Samples t-Test for the Total and Subscales of the Health-Promoting Lifestyle Profile II
_____________________________________________________________________________________________________________________
HPLP II Scale

Mean

SD

Mean difference

SD

t

p

_____________________________________________________________________________________________________________________
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HPLP II pre

2.498

0.482

HPLP II post

2.732

0.502

Health responsibility pre

2.495

0.660

Health responsibility post

2.492

0.775

Physical Activity pre

2.143

0.763

Physical Activity Post

2.466

0.658

Nutrition pre

2.362

0.665

Nutrition Post

2.684

0.847

Spiritual Growth pre

2.631

0.565

Spiritual Growth Post

2.941

0.553

Interpersonal Relationship pre

2.820

0.384

Interpersonal Relationship post

3.005

0.445

Stress Management Pre

2.485

0.766

Stress Management Post

2.750

0.640

-0.233

0.420

-2.426

0.026*

0.003

0.638

0.025

0.980

-0.322

0.649

-2.164

0.044*

-0.321

0.879

-1.592

0.129

-0.309

0.446

-2.809

0.012*

-0.185

0.446

-1.812

0.087

-0.264

0.629

-1.784

0.092

____________________________________________________________________________________________________________________

Note. * significant p value.

Table
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Summary of Goals for Some Participants Who Lost the Most Weight Compared to Those who Gained the Most Weight
_____________________________________________________________________________________________________________________

Session 1

Session 2

Session 3

Session 4____________

ID
ΔW F
V
PA
F
V
PA
F
V
PA
F
V
PA
_____________________________________________________________________________________________________________________
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014

-10.00 1.5

2

30min. 4d/wk 2

2

30min/7d/wk

2

2

30min/7d/wk

1

1

30min/7d/wk

012

-8.00 2

3

45min.5d/wk

2

3

30min/5d/wk

2

2

30 min/3d/wk 2

3

30min/3d/wk

006

-7.50 3

4

30min/5d/wk

3

3

30min/7d/wk

3

3

30min/7d/wk

3

3

30min/7d/wk

008

+4.25 2

3

15min/5d/wk

3

2

25min/5d/wk

2

3

30min/5d/wk

3

3

30min/7d/wk

019

+6.25 2

3

30min/3d/wk

1.25

2

30min/3d/wk

1.5

2

30min/3d/wk

1

2

15min/7d/wk

004

+9.00 2

3.5

30min/5d/wk

2

3.5

30min/5d/wk

2

3.5

30min/3d/wk

2

3.5

30min/3d/wk

_____________________________________________________________________________________________________________________
Note. ΔW= change in weight; F = daily cups of fruits; V = daily cups of vegetables; PA = physical activity; min = minutes; d/wk= days per
week.

Barriers and Solutions to Increasing Fruit and Vegetable Intake
During the second and third sessions, participants shared with the facilitator the
barriers to reaching their goals. They then participated in a problem solving exercise to
find solutions to the barriers that prevented them from meeting their fruit and vegetable
intake goals. Table 11 represents a summary of barriers that were shared by participants.
Stress and depression were identified as affecting the emotional well-being of some
participants and prevented them from attaining their goals. Other health issues, which
affected some participants’ ability to meet their fruit and vegetable intake goals, were
identified as including tooth pain and diarrhea. Some participants indicated that they had
difficulty affording fruits and vegetables or had run out of their food stamps.
Access to fruits and vegetables seemed to be a key concern to some participants.
Some participants who lived in adult foster care (AFC) homes indicated that fruits and
vegetables were not provided in their living setting. Lack of transportation was
mentioned by a participant as a barrier that affected the intake. Lack of support from
family and friends was also reported as a factor that affected fruit and vegetable intake.
Lack of storage space was cited by one participant. Some participants mentioned that
they found it difficult to change their prior behaviors. Busy schedules also affected
participants’ ability to attain their fruit and vegetable intake goals.
Participants were also able to find solutions to the barriers that prevented them
from increasing their fruit and vegetable intake. This is evident in Table 11 where fewer
barriers were identified at session 3. Participants identified relaxation techniques as a
means of reducing stress. Participants who indicated that their depression affected their
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goals were able to identify that they would seek assistance immediately from their case
worker, psychiatrists, or psychologist for depression.
Table 11
Barriers to Increasing Fruit and Vegetable Intake
________________________________________________________________________
Barrier

Session 2
Session 3
n reporting
n reporting
________________________________________________________________________
Lack of time

1

Dislike of fruit and vegetable

2

2

Affordability

7

2

Lack of access

2

1

Depression

2

Lack of time

1

Difficult to change

1

Lack of transportation

2

Health Problems

2

1

Lack of family/friends support

1

1

Fruit/vegetable going stale

1

1

Lack of storage space

1

Craving unhealthy foods

1

________________________________________________________________________
Total number of barriers

24

8

________________________________________________________________________
Participants with dental problems also stated they were going to follow through
with the dentist or oral surgeon. One participant, who had reported that a busy schedule
was a barrier, indicated that packing fruits and vegetables to take along in the car would
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be a solution. Having a schedule for eating fruits and vegetables was also mentioned as a
solution that would assist to increase intake.
One participant indicated that eating fruits and vegetables prior to eating other
foods would be beneficial. Adding spices to the vegetables was also identified as a
solution to improving intake. Eating fruits for dessert was identified as a solution that
could promote fruit intake. Eating fruits and vegetables consistently was also mentioned
as one solution that could promote intake. Since affordability of fruits and vegetables
was a concern, one participant indicated that he had requested the AFC home owner to
provide him with fruits and vegetables.
Buying fruits and vegetables during sales was also mentioned by participants as
one method of overcoming the barriers. Participants also indicated that it would be
helpful to learn to budget and buy and stock their fruits and vegetables when they had
food stamps. Buying just enough fruits and vegetables was identified by one participant
as a solution to preventing the supply from going stale while also addressing the problem
of inadequate storage space. To counter transportation barriers, participants identified that
they could walk to the store. Additionally, some participants indicated that they would
seek assistance from the case managers to provide them with bus tokens in order to have
transportation means to the grocery store.
Facilitators of Increasing Fruit and Vegetable Intake
During the second and third session, participants also shared with the facilitator
the reasons that had made them successful in increasing their fruit and vegetable intake
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(Table 12). Several participants indicated that they had been successful in increasing
their fruits and vegetable intake because they had free meals at a local feeding center.
Table 12
Facilitators of Increase in Fruit and Vegetable Intake
________________________________________________________________________
Facilitator

Session 2
n reporting

Session 3
n reporting

________________________________________________________________________
Availability of fruits and vegetables

5

3

Desire to eat healthy

3

4

Desire to lose weight

3

Routinely eats fruits and vegetables

1

Liking fruit and vegetables

2

5

Information, goals and resources from the project

5

3

Adding spices/seasoning to vegetable

1

Routinely/raised eating fruits and vegetables

1

1

Motivation

1

1

Family support

1

Eliminating unhealthy snacks

1

Trying new recipes

1

________________________________________________________________________
Total number of facilitators

22

20

________________________________________________________________________
One participant stated that his AFC home had started providing fruits and
vegetables in order for the participant to meet his project goals. Some participants
attributed their success at increasing fruit and vegetable intake to the desire to eat healthy
while others wanted to lose weight. Other participants indicated that they liked eating
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fruits and vegetables. Some participants indicated that their success was due to the
motivation to meet their project goals. One participant was motivated by the personal
reason to lose weight as she was participating in a family member’s wedding. One
participant indicated that cutting down unhealthy snacks had facilitated him being
successful in increasing his intake of fruits and vegetables. Adding dressing and
seasoning to vegetables was cited as a reason that enabled a participant to increase fruit
and vegetable intake. Some participants attributed their success in increasing fruit and
vegetable intake as resulting from the information that they obtained from the
psychoeducation intervention.
Barriers and Solutions for Increasing Engagement in Physical Activity
During the second and third sessions, participants also shared barriers that had
prevented them from meeting their physical activity goals. Following barrier
identification, they problem-solved to find solutions to the barriers. Barriers to physical
activity are represented in Table 13. Health problems including chronic pain, arthritis
and neuropathy were identified by some participants to have affected their ability to meet
their physical activity goals. Bad weather that included cold weather, rain, snow, and heat
also affected the participants’ ability to meet their physical activity goals. Busy
schedules, lack of motivation and fatigue were identified by participants as having
affected their physical activity goals. One participant was concerned about the safety of
the environment in which she engaged in physical activity.
In regards to chronic pain, participants identified the need to engage in physical
activity when they had no pain. Maintaining activity as tolerated and taking pain
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medication as directed by their health care providers was also provided as a solution to
the physical activity barrier. Participants also identified the need to avoid a sedentary
lifestyle. Motivating self to engage in physical activity, and seeking support from and
exercising with family members were cited as ways of improving engagement in physical
activity.
Table 13
Barriers to Physical Activity
________________________________________________________________________
Barrier
Session 2
Session 3
n reporting
n reporting
________________________________________________________________________
Health issues
4
4
Unfavorable weather

4

Fatigue

2

Lack of motivation

3

Lack of time
Safety Concerns

2

1
1

1

________________________________________________________________________
Total number of barriers
14
8
_______________________________________________________________________

Having a set schedule for physical activity was also mentioned as helpful. In
order to overcome the bad weather, participants indicated that they could engage in
physical activity in the house or postpone activity to a favorable day. The participant
who was concerned about safety stated that finding a park with lots of people and also
focusing on positive thoughts would be helpful. One participant indicated that seeking
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assistance from the case manager would be instrumental in identification of a discounted
gym membership.
Facilitators of Increase in Physical Activity in Participants
During the second and third session, participants also shared the reasons that had
made them successful in increasing the time that they participated in physical activity
(Table 14).
Table 14
Facilitators of Engagement in Physical Activity
_______________________________________________________________________
Facilitator

Session 2
Session 3
n reporting
n reporting
________________________________________________________________________
Job requires physical activity
2
1
Lose weight

2

Daily routine involve physical activity

7

Scheduling physical activity

2
1

Desire for healthy lifestyle

4

3

Motivation

1

1

Relaxation

2

1

Project goals

2

Personal reasoning (wedding)

1

Enjoys physical activity

3

Family/friends support

2

Favorable weather

2

2

4

________________________________________________________________________
Total number of facilitators

26

17

________________________________________________________________________
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Participants indicated that favorable weather conditions increased their ability to
engage in physical activity. Some participants indicated that health benefits that included
improvement of arthritis symptoms and stress reduction made them engage in physical
activity. Use of music while engaging in physical activity increased the success of one
participant.
Some participants indicated that support from family and friends made them
successful. The desire to change and improve overall health was also a motivator for
some participants. Some participants indicated that what motivated them to be successful
in physical activity was their commitment to keep their project goals. Other participants
stated that the benefits of physical activity that included improvement of their shape,
muscle strength and reduction of belly fat. Other reasons for success in engaging in
physical activity included enjoyment that was derived by participants. Motivation to lose
weight was also reported by a participant. One participant reported that he was
successful in participating in physical activity because he was now his own cheer leader.
One participant stated he was successful in engaging in physical activity when he was
well rested.
Barriers and Facilitators of Weight Loss or Gain in Participants
Some of the common themes among the participants who lost weight during the
intervention emerged related to why they were successful. They included access to
availability of fruits and vegetables, (b) desire to lose weight and maintain a healthy body
weight, (c) commitment to their project goals, (d) increased motivation, and (e)
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adherence to the teaching from the project. Overall the themes reflect that they were
eating better and were physically active.
Of the participants who gained weight, the indicated key barriers included (a)
fatigue, (b) bad weather, (c) lack of access to fruit and vegetables, (d) lack of motivation,
and (e) safety concerns. It is also notable that some of the participants who gained
weight had a high baseline weight to begin with. However, there are exceptions, for
example one participant whose baseline weight was 297.25 pounds was able to lose 6.25
pounds at the end of the intervention. Some participants who indicated that they did not
have barriers when it came to increasing their physical activity as well as intake of fruits
and vegetables still gained weight.
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CHAPTER 6
DISCUSSION

The purpose of this project was to implement a psychoeducational intervention
that would increase awareness of nutrition and physical activity for adults (aged 18 and
above) with severe mental illness who are taking antipsychotic medications. The second
purpose of the intervention was to determine if the intervention had any effect on weight,
BMI, blood pressure, pulse, waist circumference, waist/hip ratio and health promoting
lifestyles among this group of adults. The objective of this chapter is to discuss the
nutrition, physical activity and physiological outcomes. Additionally, Health-Promoting
Lifestyle Profile II questionnaire outcomes are discussed. The strengths and limitations of
the intervention are presented. In addition, the implications for nursing practice are
highlighted. This chapter also includes a discussion of the implications for future study.
In writing this chapter, the role of the DNP-prepared clinician is also highlighted. The
sustainability of the psychoeducational program in the community health clinic is also
discussed.
Discussion of Results
The need to implement non-pharmacological interventions in the management of
weight and physical illness through patient education has been supported by various
meta-analyses and literature. The literature reviewed in the project supported the use of
psychoeducation that focuses on nutrition and exercise to manage people in the target
patient population (Menza et al., 2004). Vreeland et al. (2010) supported the use of
similar interventions for promoting healthier lifestyles in people with mental illness. The
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importance of psychoeducational interventions as a means of weight management has
also been supported by literature (Littrell et al., 2003; Loh et al., 2006; Menza et al.,
2004; Wu et al., 2008). More importantly, the use of structured patient education using
verbal, written and discussion methods as implemented in this intervention has been
found to be successful in the targeted population (Fernandez et al., 2006).
Results from this project indicate that the participants who completed the
psychoeducational intervention had significant improvement in their intake of fruits and
vegetables over the eight week time period of the study. Additionally, participants also
had a significant improvement in the amount of time that they were engaged in physical
activity over the eight week time period of the study. The results of the project indicate
that psychoeducational interventions can have an impact on nutrition and physical
activity and health promoting behaviors in this patient population and can be successfully
implemented over an eight week period. These findings are consistent with the current
literature review. The results from the project demonstrate the value of promoting an
evidence-based intervention to improve health outcomes in patients with severe mental
illness who have increased cardiometabolic risk factors.
A total of 12 participants out of the 19 participants who completed the
intervention also had a decrease in weight and BMI. The overall total weight loss by the
group who participated in the intervention was 31 pounds, however the change was not
statistically significant. Despite the lack of significant change in weight and BMI, the
change in weight for the successful individuals further improves their health outcomes
and begins to reduce their individual cardiometabolic risks. The eight week
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psychoeducational intervention did not show statistically significant changes in
participants’ blood pressure, pulse, waist, and waist/hip ratio. However there was a
statistically significant decrease in the hip size of the participants. The lack of effect on
physiological outcomes calls for further study. For example, studies with a longer
duration would be beneficial to see if these parameters would change. Overall, the
psychoeducation seems to be a promising intervention that may help modify risk factors
including obesity, poor nutrition and the lack of physical activity that is prevalent in the
targeted patient population. However, follow-up of participants would be beneficial to
determine whether the benefits are sustainable after the eight week intervention period.
The total score on the 52 item scale Health-Promoting Lifestyle Profile II
questionnaire showed significant improvement after the intervention, indicating that the
intervention had an impact on the participants’ behavior associated with health promoting
lifestyles. There was improvement in the spiritual growth subscale indicating that the
psychoeducation intervention was effective in employing strategies that allowed
participants to share thoughts and feelings through verbal and nonverbal messages that
pertained to their health promoting goals and behaviors. The intervention allowed
participants to be more goal oriented, more exposed to new experiences and be more
aware of what was important in their lives as the scale items suggest. Key strategies of
the intervention that were used included participants completing multiple choice
questions and verbalizing the benefits of eating fruits and vegetables. Participants also
wrote down and verbalized their barriers and solutions to increasing fruit and vegetable
intake, and physical activity. Another activity offered was participation in a word game
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and coloring activity. More importantly, participants were able to formulate, write down
and verbalize their project goals at every session.
There was also improvement on the physical activity scale. This agrees with the
findings of the study that the participants improved their engagement in regular
participation in light, moderate and vigorous activity over the eight week study period.
Other findings in the study indicated that the participants were faced with many
barriers that affected their project goals. Health problems, financial difficulties,
transportation, lack of fruit and vegetables, safety issues, and lack of motivation were
common. Despite the challenges, these participants with mental illness were engaged in
mutual goal setting and problem solving that made several participants successful in
overcoming some of their barriers. In light of the findings of the challenges faced by this
population, the overall implication is that policy makers and the administrators of the
mental health agency need to pay attention to these barriers when it comes to future
program planning.
The completion rate of 19 participants out of the original 23 participants, is also a
key finding. This is an indication that individuals with severe mental illness can be
engaged and participate successfully in an intervention. Four participants did not
complete the intervention. One indicated that she was no longer interested in the
intervention. Two male participants did not provide a reason for dropping out. Another
male participant who dropped out indicated that he had problems with transportation.
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Community Mental Health Clinic Environment and Interprofessional Team
It was imperative to assess the project site in order to understand current efforts
related to health, nutrition and exercise teaching. The project site is designated as a
Community Case Management site. The Community Case Management is one of the
divisions of a larger mental health organization in a mid-western city in the United States.
Community Case Management is one of the providers for the community behavioral
health authority in the county where it is located. The clients who are served by the
Community Case Management are referred from the community behavioral health
authority after eligibility for Case Management services has been determined.
The Community Case Management agency is a medically necessary service
designed to assist individuals who have a serious mental illness or co-occurring disorder
(mental health, medical health, or substance use) to develop and implement strategies for
obtaining strength-based and individualized services and supports. These are identified
through a person-centered planning process.
The case managers at Community Case Management assist the clients in applying
for benefits such as social security and government assistance such as Medicaid. Clients
also receive assistance in finding resources like housing and access to substance abuse
recovery programs. Mental health clients receive medical services from an onsite
integrated medical clinic. The staffing of the integrated clinic consists of one onsite
psychiatrist, one telepsychiatrist, and a psychiatric nurse practitioner. The clinic employs
three registered nurses; one is full time while two are part time.
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Efforts to Address Chronic Conditions at the Project Site
The project site has identified physical health and wellness as a desired goal for
the clients it serves. The site provides wellness groups that are conducted by case
managers to emphasize preventive care and management of chronic health conditions.
These wellness groups could focus more regularly on diet and physical activity. In order
to address wellness needs for the population, the project study location uses enhanced
primary care coordination services. Clients with cardiovascular diseases, asthma, COPD,
obesity and diabetes are referred to primary care services to ensure a continuum of care.
Role of Case Managers in Addressing Chronic Conditions
There are a total of about ten case managers who are both Bachelors and Master’s
level social work clinical staff. The screening for enhanced service starts with the initial
psychosocial assessment that is completed by the case workers during admission. The
coordination of primary care is provided to all Case Management clients. The role of the
case managers in terms of health promotion is to screen for co-morbid conditions. The
case managers also assist the clients in becoming established with a primary care
physician. Additionally, they coordinate information between Community Case
Management and primary care offices. They are required by organizational policy to set
a minimum of one goal addressing general health/wellness with the client. The site has a
list of health clinics, which was created by a registered nurse, where the case managers
can refer the clients. The clients are referred to clinics that provide care to uninsured
patients or charge a flat rate. The clients can also be referred to medical clinics that offer
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financial assistance to qualifying patients. The case managers are required to document
contacts with the primary care providers in case files.
The role of the case managers is to coordinate the services of the clients. Since
they see the clients more frequently than the medical staff, their role in health promotion
is crucial. The case workers should be well trained and provided with adequate resources
in order to play a key role in the health promotion of the clients. However, because the
case managers do not have a medical background it is necessary for the organization to
establish workshops and health education resources that will enhance their knowledge
and skills.
Role of Registered Nurses in Addressing Chronic Conditions
The registered nurses (RNs) are based in the Integrated Medical Clinic. They are
responsible for the patient assistance program. They provide support to the psychiatrist
when clients have appointments for a psychiatric visit. They also provide triage services
by being available for questions. Additionally, RNs review labs and facilitate follow up
with the psychiatrists or primary care physician as appropriate. They are responsible for
obtaining vital signs and reporting to the psychiatrist during office visits. The RNs are
responsible for performing nursing assessments. They provide health education in
telephone or face-to-face encounters during appointments or walk-ins. Additionally, they
maintain contact with the primary care doctor to coordinate treatment plans. The RNs are
also available for case consultation with the case managers.
The Psychiatric Nurse Practitioner is responsible for management of clients
during their visit to the Integrated Medical Clinic. Additional duties include ordering

102

labs related to psychiatric medications or conditions. The Psychiatric Nurse Practitioner
is also responsible for recommending clients who need referrals to primary care. The
Psychiatric Nurse Practitioner could expand the role by implementing standards of care
for managing metabolic syndrome and diabetes associated with psychiatric medications.
While the current role of the RNs focuses on the management of mental health
conditions, expanding the role to screening for comorbid conditions would be more
beneficial to the organization’s clients. In an expanded role, the RNs could provide
information and support for areas of health, nutrition, and exercise. They are well
prepared for this role and possess the required skills. The RNs and the Psychiatric Nurse
Practitioner are able to use models like the Health Promotion Model (HPM) to entrench a
health promotion initiative in the organization. The use of a manualized
psychoeducational intervention for diet and physical activity could be easily
implemented.
Role of Peer Support Specialist in Addressing Chronic Conditions
The peer support specialists help consumers with their identified selfmanagement strategies. Additional duties include assisting the consumer with decision
making and community linkages. The peer support specialist is responsible for
supporting self-management approaches, therefore, another key role could include health,
nutrition and exercise teaching in conjunction with the health care providers.
Role of the Psychiatrist
The psychiatrist role is to diagnose and treat mental illness, including addiction
and substance use. The psychiatrist also refers patients appropriately to primary care
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physicians and other specialists as deemed appropriate. At the project site,
pharmacological management for overweight and obesity is not a common a practice.
However, reviewing and changing medications in the case that a client is gaining weight
from an antipsychotic medication are common interventions. The integration of the
psychoeducation intervention would therefore be beneficial as a means of managing
clients who are at risk for overweight and obesity. The psychiatrist could also support the
implementation of standards of care related to metabolic syndrome and diabetes
associated with psychiatric medications.
Integrating the Intervention at the Study Site
It is important to understand the possibility of successfully integrating the
intervention at the project site. The facilitator could offer the organization a plan that
addresses the barriers and facilitators that were identified during the intervention. The
facilitator could also suggest next steps to implementation which may include (a) staff
training, (b) use of the psychoeducational manual, and (c) the possibility of entrenching
the intervention in the electronic health record or intranet of the institution as an
educational module for case managers, RNs, peer support specialists and as a tool to
educate the clients in the form of a presentation, such as Power Point.
The inexpensive nature of the intervention may make it attractive for the mental
health agency. The implementation of this intervention was supported by a grant from
Kirkhof College of Nursing, Vulnerable Population Center of Distinction. Table 15
represents the expended funds for supplies for the psychoeducation intervention. In
addition to the money spent, the time spent by the facilitator to meet with the participants
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should be considered. Each participant who completed the intervention met with the
facilitator for four, 45 minutes sessions during the 8 week period. Obviously, the per
patient time would increase as on-going support beyond eight weeks is included. Once
started, this support could be in the form of individual or group support or both,
depending on efficiency needs and what is required to sustain individual outcomes.
Table 15
Project Costs
________________________________________________________________________
Item

Price/Unit

Total Cost

_______________________________________________________________________
25 measuring cups

$2.97

$78.71

25 canvas tote bags

$1.99

$52.73

25 placemats

$5.00

$125.00

2 bags of Apples

$4.00

$8.00

12 packets, mixed vegetables

$2.00

$24.00

________________________________________________________________________
Total Cost

$288.44

________________________________________________________________________
Usefulness of Health Promotion Model and Chronic Care Model
These models served to facilitate a collaborative interaction between the
facilitator and the participants. The HPM also provided the facilitator a conceptual
framework for the delivery of the intervention. Furthermore the model was useful in
providing a framework to assess the health-promoting behavior of participants prior to
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and after the psychoeducational intervention. Health promotion is the foundation of
prevention and management of chronic illness. Since the goal of this project was to assist
the participants to change their behaviors and achieve desired improvement of their
health risks by maintaining healthy lifestyle behaviors, the HPM supported the design
and the delivery of the psychoeducation intervention. Additionally, the HPM was the
appropriate model to explain the results of the psychoeducation intervention. While
physiologic measures failed to show significant change (except for hip size), the goal
setting process resulted in a significant change of health behaviors.
The CCM provided a conceptual framework to explore the complexities of
implementing a psychoeducational intervention project in a Community Mental Health
Clinic that provides care to clients with chronic mental illness. The success of the
delivery of the psychoeducation intervention was supported by the CCM model. The
CCM model could be used as a framework to sustain this type of program in the future
for this organization. The CCM model supports the use of evidence-based practice
through a collaborative approach to care delivery that includes collaboration with the
client and an interdisciplinary team. The CCM provided a framework to the facilitator to
identify resources to enhance the implementation of the intervention. The CCM further
enhanced the formation of a partnership with participants during the implementation of
the intervention. More importantly, the CCM facilitated the assessment of the
organization with the goal of developing a plan for successful project implementation and
future sustainability. The CCM further supported the key principle of chronic disease
management. The need to complement an engaged and committed patient with an
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informed care team is fundamental to effectively manage obesity and associated
cardiometabolic risk factors. The organization can use the CCM to plan and implement a
similar program for their clients by supporting the use of evidence-based education
interventions when providing client education. Training of the registered nurses (RNs)
who have the required health knowledge to offer the psychoeducation program while
having the case managers offer supported follow up to the clientele is one feasible way of
implementing and sustaining the intervention.
Strengths of the Project
This study has several strengths. One strength is that it was theory driven. Moran,
Burson, and Conrad (2014) propose that the intervention in the scholarly project should
be directed by the theoretical framework. In this project the Health Promotion Model and
Chronic Care Model were used as the theoretical frameworks. More importantly, this
study provided a great opportunity for interdisciplinary collaboration in the community
mental health clinic setting. Strength for the intervention is further derived from multiple
clinical guidelines that address the management of chronic illnesses in the United States
of America. The simplicity and measurements of key outcomes is another strength of
the intervention. Since the intervention was conducted by one facilitator there was
consistency in the application of the intervention and outcomes measures. The
participants in the project were also from diverse ethnic backgrounds and age groups.
They were representative of the clientele served in the Case Management caseload. The
intervention utilized various strategies including phone call reminders to retain study
participants. The participants were provided with tools that reinforced the teaching of the

107

intervention like the measuring cup and placemats. The use of strategies like reviewing
previous sessions also reinforced the educational content. The clients who participated
were motivated to engage in the educational intervention. Finally, the grant received
from Kirkhof College of Nursing, Vulnerable Population Center of Distinction, was a
validation of the importance of addressing health outcomes of patients with severe mental
illness.
Limitations of the Project
The limitations of the current project include the small sample size (n=19) and
convenience sample of participants. This affects its generalizability. Despite this, it does
provide some support for the use of this type of intervention in this type of setting. In
addition, with the relatively short implementation period, it is impossible to determine
whether the benefits would be improved and sustained over a longer time. The self-report
approach in obtaining data for the Health-Promoting Lifestyle Profile II questionnaire,
reported fruit intake, vegetable intake, and physical activity level was a threat regarding
the accuracy of the data. Polit and Beck (2008) indicate that self-report questionnaires are
subject to possible threats, for example response bias or social desirability. Reliability
related to standardized procedures for obtaining biological measurements is also a study
limitation.
Implications for Future Intervention Implementation
The current project utilized a small sample size. Future recommendations include
using a larger sample. The time frame for the study was also short and included only four
sessions. In designing a future study, a longer time frame and more sessions would be
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important. There was no opportunity for a longer period of follow-up after the
intervention. Future projects or actual interventions should incorporate long term followup for participants to ascertain whether the benefits are sustained. Barriers and
challenges that face patients with mental illness should be considered and addressed
while conducting similar interventions. Clients with severe mental illness can be engaged
with supported follow up which in turn may lead to their being successful in achieving
goals for healthy nutrition and engaging in physical activity.
Whether this type of intervention is studied further or implemented in a site such
as the Case Managements agency, several conclusions are evident from this project.
Clients are capable of identifying health related goals that can be successfully obtained
with appropriate education, facilitation, and support. The success of this brief
intervention suggests benefits for a longer-term intervention. The roles of the
interdisciplinary team can be broadened to support evidence-based interventions and
standards of care for this at-risk population. Finally, the role of the DNP prepared nurse
could be vital to implementing and sustaining system changes that enhance the lives of
this vulnerable population. The overall implication is the need to implement and
document the outcomes of nurse-led interprofessional practice teams to patient outcomes.
Barriers and Facilitators of Integrating the Intervention
Apparent barriers to the integration of the proposed intervention include staff,
time, knowledge and cost. The staff may be resistant to change what is needed to
entrench the proposed intervention. Lack of time for additional duties may be a potential
barrier to the staff employed by the organization. Some staff including Case Managers
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may cite lack of knowledge and skills to implement the proposed interventions. To the
organization, the integration of the proposed intervention may require some restructuring
of the staff duties or addition of staff members including an RN. The organization may
consider this as time consuming and costly.
The organization and all staff members can be effective as facilitators of the
proposed intervention. The organization can be a key facilitator of the integration of the
proposed intervention. With the passage of the Affordable Care Act (ACA) it is
necessary for the organization to transform the health care delivery system for improved
patient outcomes in the management of chronic conditions. Currently the organization
has a Behavioral Health Care Pilot program whereby clients are screened and assessed to
determine if they have higher primary care at-risk conditions to facilitate enhanced
primary care coordination services. Furthermore provision of comprehensive coordinated
care improves patient outcomes and decreases health care costs.
RNs in the organization are well trained in health promotion and client education
and can facilitate the integration of the proposed intervention after receiving the
necessary training. They can also collaborate with the case managers by providing inservices to educate the case managers on the implementation of the intervention. The
lead case manager can be educated on the intervention and be responsible for educating
new case managers on how to implement the intervention. All case managers need to be
facilitators in the integration of the intervention since they are responsible for providing
health and wellness education to the clients and for identifying one physical health
related goal. They can facilitate the integration of the proposed intervention by
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recommending it as a resource that would be beneficial in their daily role. The
Psychiatrists and Psychiatric Nurse Practitioner who are the key health care providers can
facilitate the implementation of the intervention by recommending that patients who are
overweight or obese or who are receiving psychiatric medications that carry these risks
be referred for the nutrition and physical activity education by the Case Managers, RNs
and Peer Support Specialist using the proposed intervention. In conclusion, the presence
of an interprofessional team, with various levels of expertise within this organization
provides it with a great ability to entrench the psychoeducation intervention.
Doctor of Nursing Practice (DNP) Roles
Several significant roles associated with the Doctor of Nursing Practice (DNP)
degree were exemplified by the facilitator of this project. With the introduction of the
Doctor of Nursing Practice (DNP) degree, the DNP prepared clinician should be prepared
to contribute significantly to the practice environment by engaging in translation of
evidence-based practice. Furthermore, DNP prepared clinicians are focused on clinical
practice at the highest standard level of practice (American Association of Colleges of
Nursing [AACN], 2004). According to the AACN, one role of the DNP prepared advance
practice nurse is to become an innovative leader in the transformation of the current
health care system. Furthermore, Moran et al. (2014) indicate that work that is done in
relation to improving patients and healthcare systems is increasingly viewed as important
in contributing to knowledge that can be amassed and shared to produce further
improvements. The Essentials of DNP education (AACN, 2006) identify enhancements
to the advanced practice nurse’s knowledge and skill set. Additionally, Moran et al.
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support the identification of the specific essentials that are demonstrated in the project to
confirm evidence of doctoral-level work.
Essential I is the Scientific Underpinnings for Practice which was demonstrated in
this project. The facilitator integrated nursing science with information from the mental
health organization. To improve participants’ outcomes, the psychoeducation intervention
was supported by nursing theory, a theory from a different discipline, and from published
literature.
Essential II, which is Organizational and Systems Leadership for Quality
Improvement and Systems Thinking, was also demonstrated. According to AACN
(2006), DNP graduates should display expertise in assessing organizations, identifying
system issues, and facilitating organization wide changes in practice delivery. While
developing and implementing this intervention, the investigator was interested in
approaches that met the current and future needs of the target patient population and the
organization that served them.
The investigator also demonstrated Essential III, which is Clinical Scholarship
and Analytical Methods for Evidence-Based Practice. Existing literature was evaluated
to support the intervention. Additionally, the intervention involved systematic evaluation
of outcomes of the participants in the mental health agency.
Another essential that was addressed in the intervention was Essential IV,
Information Systems/Technology and Patient Care Technology for the Improvement and
Transformation of Health Care. Supertracker, an online tool, was selected and utilized
during the intervention to recommend fruit and vegetable intake among participants.
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Data management and incorporating agency requirements for the use of electronic health
records and confidential personal information also used information technology.
Essential V is Health Care Policy for Advocacy in Health Care. Providing an
intervention that was based on scientific knowledge to a target population that could
benefit was part of this project. It is important to provide quality care that is responsive to
vulnerable populations in order to ensure equity in improved health outcomes.
Interprofessional Collaboration for Improving Patient and Population Health
Outcomes, Essential VI, was also part of this project. The investigator collaborated with
other members of the organization including the team leader and case managers to
enhance the success of the intervention. The investigator analyzed how organizational
and professional roles might be redesigned to implement this type of intervention in the
future.
Essential VII is Clinical Prevention and Population Health for Improving the
Nation’s Health and is also important for the DNP graduates. While implementing this
intervention the investigator participated in health promotion and risk reduction activity.
Additionally, the evaluation and interpretation of the current project data may influence
methods that can improve our nation’s health.
Finally, Essential VIII is the Advanced Nursing Practice which was clearly
demonstrated by the investigator. While implementing this intervention the investigator
incorporated a psychoeducation approach which is supported by the literature in
managing lifestyle and medications in the target population. The investigator formed
partnerships with participants as well as agency staff with the goal of improving patient
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outcomes. The process also involved the development of clinical decision making skills
and critical thinking. Evaluation of evidence-based care was also an advance nursing
practice competency that was utilized while developing the intervention.
Conclusion
Clients with severe mental illness have increased cardiometabolic risk factors.
Individual lifestyle choices that include unhealthy diet and inactivity are prevalent in this
population. Psychotropic medications also have an impact on physical health problems of
patients with severe mental illness. DNP prepared clinicians can be at the forefront of
implementing interventions that decrease risk factors by engaging patients in
psychoeducational interventions. Changing behaviors or maintaining healthy lifestyles is
difficult for patients with severe mental illness. The outcome of this intervention revealed
how a DNP educated clinician may implement an intervention to effectively educate
patients with severe mental illness on the need to modify their increased cardiometabolic
risk. Additionally, providing clients with simple tools that might contribute to success
like measuring cups or placemats that reinforce educational content, is another valuable
consideration. Individual goal setting and supported follow-up utilized by the facilitator
while conducting the intervention would be worthwhile to consider for this and similar
agencies serving this clientele.
Finally, the organization can consider this project as one feasible way of
implementing a psychoeducation intervention. Using the CCM model to develop training
of the registered nurses (RNs) who have the required health knowledge to offer the
psychoeducation program and the case managers to offer supported follow up to the
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clients is a feasible way of implementing and sustaining this type of intervention. The
feasibility of this intervention can be further enhanced by incorporating modules in the
EHR, using existing online programs like SuperTracker, and creating a standardized
workbook for implementation. The CCM model and the AACN Essentials for DNP
education support the full engagement of clients with a multi-disciplinary team to achieve
sound health care goals.
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Appendix A
Health Promotion Model Copyright Permission
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from:
to:
date:
subject:

Nola Pender <npender@umich.edu>
Alice Mwanda <mwandaa@mail.gvsu.edu>
Mon, Feb 25, 2013 at 9:20 AM
Re: Permission to use the health promotion theory diagram

Dear Alice:
You have my permission to use the Health Promotion Model in your work and to reprint
a diagram of the Health Promotion Model in your proposal and written dissertation. I
wish you success with your academic work.
To Your Health,
Nola Pender
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Appendix B
Chronic Care Model
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Figure 2. Chronic Care Model. Reprinted from “Chronic Disease Management: What Will It Take
to Improve Care for Chronic Illness?” E. H Wagner, 1998, Effective Clinical Practice, 1998,
Vol1, Reprinted with permission from American College of Physicians (See Appendix P).
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Appendix C
Grand Valley State University Human Research Review Committee (HRRC) Approval
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Appendix D
Pine Rest Christian Mental Health Services Approval

125

126

Appendix E
Recruitment Script for Case Managers
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RECRUITMENT SCRIPT
February 25, 2014
Dear ______________________,
During the Winter/Spring 2014, you will have the chance to be part of a special
project led by a Family Nurse Practitioner, who is a Doctor of Nursing Practice (DNP)
intern.
The aim of the project is to improve your health promoting lifestyle and have a
positive effect on your physical health including weight, BMI, blood pressure and waist
circumference. If you choose to be part of this project you will be able to meet with the
project leader for four 45 minutes individualized sessions (visit).
Whatever you share with the project leader as part of participating in this project,
will not be shared outside the Clinic in any way that connects the information to you. If
you have any concerns or questions about being part of this project, the project leader
will be happy to speak with you.
Thank you!

Alice Mwanda, MSN, FNP, RN
Doctor of Nursing Practice Intern and Project Leader
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Informed Consent for Participants
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CONSENT TO TAKE PART IN A PROJECT AND
AUTHORIZATION TO DISCLOSE HEATH INFORMATION
Project Title: The Effectiveness of a Psychoeducational Intervention on Health
Promoting Behaviors and Physical Health of Adult Patients (18 and over) on
Antipsychotic Medications
Principal Investigator (s):

Alice O. Mwanda, MSN, FNP, RN
Doctor of Nursing Practice Student
Cook DeVos Center for Health Sciences,
Kirkhof College of Nursing, Grand Valley State University
301 Michigan St. NE, Grand Rapids, MI 49503-3314,
Phone (269) 532 9288
Andrea Bostrom, Ph.D., PMHCNS-BC,
Professor of Nursing and Dissertation Chair
Cook DeVos Center for Health Sciences,
Kirkhof College of Nursing, Grand Valley State University
301 Michigan St. NE, Grand Rapids, MI 49503-3314,
Phone (616) 331 7172
Jeffrey Madigan, MA, LPC
Team Lead, Case Management Services
Pine Rest Christian Mental Health Services
300 68th ST. SE, Grand Rapids, MI 49501
Phone (616) 281-6363 ext. 2902

Project Location:

Community Case Management Services
Pine Rest Christian Mental Health Services
300 68th St. SE,
Grand Rapids, MI 49501

You are being asked to participate in a project study. In order to decide whether or not
you should agree to be part of this project, you should receive enough information about
its procedures, risks and benefits to make a judgment. This process is called informed
consent. This consent form gives detailed information about the project. Your
participation is totally voluntary. If you wish to participate in this project you will be
asked to sign this form.
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Description of the project
The purpose of this project is to learn more about the effectiveness of a
psychoeducational intervention on health promoting behaviors and physical health among
persons on antipsychotic medications. You were referred for the project by your case
manager. To participate, you must be at least 18 years old and taking at least taking one
antipsychotic medication.
Project Procedures
If you decide to take part in this project,
1.
2.
3.

4.

5.

6.

7.

You will be asked to attend four sessions (visits), lasting 45 minutes over eight
weeks.
Your medical record will also be reviewed to obtain information on your mental
health diagnosis and names and doses of your prescribed medications.
During your first meeting or the informational session with the project leader,
you will be asked to provide information about your gender, ethnicity and age.
The project leader will obtain measurements of your weight, height, blood
pressure, pulse, waist and hip size. She will also calculate your BMI and
waist/hip ratio. The project leader will also ask you to complete a 52 item
questionnaire on your health promoting lifestyle that will take about 20 to 30
minutes during the first and the last session.
During the four sessions, the project leader will facilitate an individualized
educational intervention as well as provide you with supported follow-up with
the aim of establishing your goals for diet and exercise. Additionally the
intervention is aimed at assisting you improve your physical health and reduce
your weight. The sessions in the intervention will stress the importance of
improving fruit and vegetable consumption and physical activity. The sessions
have been designed to motivate and build your skills using simple tools that will
assist you to achieve your nutrition and physical activity goals.
During the second, third and fourth sessions, measurements of your weight,
height, blood pressure, pulse, waist and hip size will be obtained again. The
leader will also calculate your BMI and waist/hip ratio again. This information
will be shared with you in writing and with your case manager with your
permission.
In order to protect your right to have your personal information kept private,
whatever you share with the project leader will not be shared outside of the
Clinic in any way that connects the information to you. The data collection
documents will be coded to keep them together during the project. At the
completion of the project the code list will be destroyed.
Your protected health information (PHI) will not be taken off site. A hard copy
“source” documents (data collection tools) will be kept in a locked file at Pine
Rest Case Management. Electronic data will be securely stored in Sharepoint
after being entered from the hard copy source documents into a spreadsheet this data will be de-identified. Your de-identified data will be downloaded onto a
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8.

9.

password protected USB prior to being taken to GVSU. A separate master list
linking your name to your assigned study ID will also be kept. Electronic copies
of approved protocol, informed consent and data collection tools will also be
kept in share point.
The facilitator of the project will not be given full access to your chart. Jeffrey
Madigan can pull the data needed for the project (psychiatric diagnosis and
medication information) or the facilitator will only be granted access to this
information.
Alice O. Mwanda will obtain the informed consent, Jeffrey Madigan will come
in immediately afterwards to answer questions/concerns you may have and to
confirm your understanding and then sign off on the informed consent. As a
participant, you will receive a copy of the signed informed consent .

Voluntary Participation and Withdrawal
Participation in the project is completely voluntary and you may withdraw anytime
without penalty. Before agreeing to participate, you may discuss it with someone who is
not associated with this project. If you decide to take part in the project and later change
your mind, you may withdraw or discontinue participation at any time, as well.
Whatever you decide, you will not be penalized or lose any benefits to which you are
otherwise entitled nor will your decision have any effect on your current or future
relationship with Pine Rest or affiliated health care provider. Formal withdrawal of your
consent to participation in this project can be done by notifying Alice O. Mwanda, Dr.
Andrea Bostrom or Jeff Madigan. Their contact information is located on the first page
of this informed consent document.
The project staff can also withdraw you from the project without your consent, if needed.
The following are some examples why this would happen:
1. You are unable to comply with or complete the project procedures within the
outlined project schedule.
2. Project staff decides that participation is not in your best interest.
3. The project is stopped.
Any project information or data recorded resulting from your participation in this project
prior to the time of withdrawal may continue to be used and disclosed by the project staff
for the project purposes described.

Risks or Discomforts of this Project
There may be some minimal risk or discomfort to you as a project participant:
1. You may feel inconvenienced by the questionnaires or distressed by being asked
questions that may be uncomfortable for you. You are encouraged to speak with
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your treatment team about any discomfort, anxiousness or distress you may
experience. Remember, you may take a break at any time or even stop project
participation, if needed.
2. There is a risk of a breach of confidentiality (privacy), although there are many
safeguards in place to prevent this which are explained later in this consent
document. To minimize this risk data will be coded during the project. At the
completion of the project the code list will be destroyed.
Benefits of this Project
Participation in this project may be a benefit to your health promoting behaviors
including dietary and physical activity habits. The participation may also lead to an
improvement of your physical health. Because this is an evidence-based research
translation project the outcomes for individual participants cannot be predicted in
advance. There may be no benefit to you from participating.
Alternative Procedures
If you do not want to be part of the project, you may choose not to participate and will
continue to receive the same treatment in the agency.
Costs and Compensation for Project Participation
Neither you nor any third party insurance provider will be billed for project-related
procedures. No monetary compensation will be given to you for your participation.
Confidentiality and Access to Identifiable Information
Although we cannot guarantee absolute confidentiality and privacy, any information
about you obtained from this project will be kept as private as possible to the maximum
extent required by law. However, during your participation, if you indicate risk of
possible harm to yourself or others, your doctor and/or clinician will be notified.
In order to keep your health information private, you will be assigned a project number
that will be used instead of your name to code project documents pertaining to your
participation in the project. The data collected and analyzed will be indicated by this
project number only. A master key linking your name to your project code will be
maintained separately from your project file in a secure location. Your project file will
be stored in a locked file cabinet. Only authorized project personnel will have access to
these records. The investigators may continue to use, for the purposes described above,
identifiable information related to your participation for the duration of the project.
You have the right to see and get a copy of your project records for as long as the
investigator has this information; however, you might not be able to review or receive
some of the records until after the project has been completed.
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Project related monitoring, audits and inspections by members of the Grand Valley State
University Human Research Review Committee and other regulatory authorities will be
permitted as required. Additionally, the investigators may be required to release
identifiable information from your project record in response to an order from a court of
law.
For data analysis purposes, all project data collected will be sent in a secure manner to
the Grand Valley State University project staff in Grand Rapids, MI using an encrypted
USB drive. Data sent to Grand Valley State University will only be identified by your
unique project number and will not contain personal identifiers (e.g., name, address,
social security number). If information from this project is published or presented at
scientific meetings, your name and other personal information will not be used.
Questions and Concerns
If you have any questions or concerns about this project, please contact Alice O.
Mwanda, Dr. Andrea Bostrom or Jeffrey Madigan. Their contact information is listed on
the first page of this document.
If you have any questions or concerns about your rights as a participant in this project,
please direct them to:
Human Research and Review Committee
Grand Valley State University
301C DeVos Center
401 Fulton Street
Grand Rapids, MI 49504 U.S.A
Phone: 616-331-3197
Email: hrrc@gvsu.edu
HIPAA Authorization
As part of this project, you are being asked to release your health information. The Health
Insurance Portability and Accountability Act (HIPAA) permits a hospital or doctor’s
office to use or release protected health information (PHI) for the purposes of treatment,
payment or health care operations. A HIPAA authorization gives permission from you to
use or release PHI for project purposes, and is in addition to your consent to participate in
this project.
In working with the sponsor, the investigator, Alice O. Mwanda, will use and
share personal health information about you. This is information about your
health that may also include your name, address, telephone number or other facts
that could identify the health information as yours. This includes information in
your medical record and information created or collected during the project. This
information may include your medical history, physical exam and laboratory test
results. Some of these tests may have been done as part of your regular care. The
investigator will use this information about you to complete this project.
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In most cases, the investigator will use your initials and assign a code number to
your information that is shared with the sponsor. The sponsor and its
representative may review or copy your personal health information at the project
site. Regulatory authorities and the Grand Valley State University Human
Research Review Committee, Pine Rest Christian Mental Health Research
Committee Institutional Review Board may also review or copy your information
to make sure that the project is done properly or for other purposes required by
law.
By signing this Authorization, you allow the investigator to use your personal
health information to carry out and evaluate this project. You also allow the
investigator to share your personal health information with:
 the sponsor and its representatives
 Grand Valley State University Human Research Review Committee
 the U.S. Food and Drug Administration (FDA)
 Other regulatory agencies - e.g. National Institutes of Health (NIH),
Department
of Health and Human Services (DHHS)
Your personal health information may be further shared by the groups above. If
shared by them, the information will no longer be covered by the Privacy Rule.
However, these groups are committed to keeping your personal health
confidential.
You have the right to see and get a copy of your records related to the study for as
long as the investigator has this information. However, by signing this
Authorization you agree that you might not be able to review or receive some of
your records related to the project until after the project has been completed.
You may choose to withdraw this Authorization at any time, but you must notify
the investigator verbally or in writing. Notify Alice O. Mwanda of your wish to
withdraw by contacting Alice O. Mwanda at Cook DeVos Center for Health
Sciences, Kirkhof College of Nursing, 301 Michigan St. NE, Grand Rapids,
MI 49503-3314 or 269 532 9288. Or you may contact Dr. Andrea Bostrom at
Cook DeVos Center for Health Sciences, Kirkhof College of Nursing, 301
Michigan St. NE, Grand Rapids, MI 49503-3314 or 616 331 7172. Or you may
contact Jeffrey M. Madigan at 300 68th St. SE, Grand Rapids, MI or 616 222
4570. If you withdraw from the project and withdraw your Authorization, no new
information will be collected for study purposes unless the information concerns
an adverse event (a bad effect) related to the project. If an adverse event occurs,
your entire medical records may be reviewed. All information that has already
been collected for project purposes, and any new information about an adverse
event to the project, will be sent to the project sponsor.
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If you withdraw from the project but do not withdraw your Authorization, new
personal health information may be collected until this project ends. This
authorization expires on 12/31/2014.
If you do not sign this Authorization, you cannot participate in this project or
receive project-related treatment. If you withdraw this Authorization in the
future, you will no longer be able to participate in this project. Your decision to
withdraw your Authorization or not to participate will not involve any penalty or
loss of access to treatment or other benefits to which you are entitled.
DOCUMENTATION OF INFORMED CONSENT
By signing this consent form and HIPAA authorization and by initialing each page, I
certify I have read this form, I have had the opportunity to ask questions about this
project and this form, and I have received answers that fully satisfy those questions. I am
voluntarily signing this consent form and HIPAA authorization as evidence of my
decision to participate in this project and I am giving authorization for release of all my
protected health information relative to project.
I am aware I may withdraw my consent and HIPAA authorization in writing or verbally
at any time without harming my future medical care or losing any benefits to which I
might be otherwise entitled. I have been advised that the investigator in charge of this
project may discontinue my participation in this project if it is felt to be in my best
interest, if I do not follow the project requirements, or if the project is stopped.
I will receive a signed copy of this Project Informed Consent Form and HIPAA
Authorization.

By signing this consent form, I have not waived any of my legal rights or released the
parties involved in this project from liability for negligence.

_____________________________________________
Printed Name of Project Participant
___________________________________________
Signature of Project Participant

__________
Date

___________
Time

_____________________________________________
Printed Name of Person Obtaining Consent
_____________________________________________
Signature of Person Obtaining Consent
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__________ ___________
Date
Time

Appendix G
Participant Data Collection Sheet

137

138

Appendix H
Health-Promoting Lifestyle Profile II
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Appendix I
Estimated Caloric Needs
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Estimated Calorie Needs. Model. Reprinted from “Dietary Guidelines for Americans” United
States Department of Health and Human Services and United States Department of Agriculture,
2010.
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Appendix J
Goal Setting Handout
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Appendix K
Placemat for participants
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Appendix L
Word Game
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Appendix M
Word Game Answer Key
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Coloring Pages

153

154

155

Appendix O
Recipe
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Appendix P
American College of Physicians Copyright Permission
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WAECP1318063
January 5, 2015
Grand Valley State University
1 Campus Dr.
Allendale, MI 49401-9403
Dear Ms. Mwanda;
Thank you for your request for print (Doctoral Dissertation) format of the following from
Effective Clinical Practice:
Figure 1, Effective Clinical Practice, 1998, Vol1, Chronic Disease Management: What Will It Take
to Improve Care for Chronic Illness? Wagner EH

Permission is granted to print the preceding material with the understanding that you will give
appropriate credit to Effective Clinical Practice as the original source of the material. Any
translated version must carry a disclaimer stating that the American College of Physicians is not
responsible for the accuracy of the translation. This permission grants non-exclusive, worldwide
rights for this edition in print (Doctoral Dissertation) format of for not for profit only. ACP does
not grant permission to reproduce entire articles or chapters on the Internet unless explicit
permission is given. This letter represents the agreement between ACP and ALICE MWANDA,
MSN FNP for request WAECP1318063 and supersedes all prior terms from the requestor.
Thank you for your interest in Annals of Internal Medicine. If you have any further questions or
would like to discuss the matter further, please contact me at 856-489-8555 or fax 856-489-4449.
Sincerely,
Gina Brown
Permissions Coordinator
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Appendix Q
Dr. Susan Walker Copyright Permission to Use Health-Promoting Lifestyle Profile II
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